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VABSTRACT
Since its discovery in 1908, the protozoan Toxoplasma gondii has been 
found to be one of the most versatile and prolific of all parasites. 
Infections with T. gondii have been reported from most parts of the 
world in humans, animals and birds. Toxoplasma has recently been 
shown to be a coccidian, which has developed from a one-host to a two- 
host cycle. The definitive hosts are felines, in whose gastro-intestinal 
tracts the isosporan phase of development takes place. The toxoplasmic 
phase occurs in many organs of other animal and bird hosts. Trans­
mission occurs via ingestion of oocysts shed by cats or cysts contained 
in raw or inadequately cooked meat, particularly mutton and pork.
Infections in humane occur at rates of up to 6% oer year or 
higher. The major complication of infection is congenital transmission 
if acute infection occurs during pregnancy. Maternal infection rates 
of 10 to 115 per 10 000 pregnancies occur in different parts of the 
world, witi up to 40% of such infections resulting in congenital infec­
tions. Fortunately, only about 15% of foetal infections are severe 
and 20% mild, with the remainder being asymptomatic.
The prevalence of toxoplasmosis varies in different parts of the 
world, being highest in hrC humid climates and lowest in cold or arid 
climates. In Southern Africa, the overall prevalence found in these 
studies was 21%, varying from 30% in Natal to 10% in the Orange Free 
State. Prevalence varied with ethnic group, from 9% in the San (Bushmen) 
of South West Africa and Botswana to 28% in Coloureds and Indians. 
Prevalence ir. Whites was lower than in other ethnic groups in South 
Africa. The annual incidence of toxoplasmosis in Southern Africa is 
about 1% up to the age of 25 years, falling thereafter to 0.5%.
The incidence of toxoplasmosis during pregnancy was studied, and 
20 acu.e infections were detected in 6705 pregnancies (0.03%) in 3 
Johannesburg hospitals. Congenital transmission occurred in 2 of these 
20 patients, and resulted In 1 severely affected and 1 asymptomatic 
infant. This congenital transmission rate of 10% is low compared to 
up to 40% found in other countries.
Transmission of toxoplasmosis in Southern Africa appears to involve 
both cysts and oocysts, although oocysts appear to be more important 
in the younger age groups. Virulence and congenital transmission rates 
are low. The estimated number of maternal infections in South Africa 
is 2 500 per year, resulting in 250 congenital infections. Thirty-eight 
of these congenitally infected babies would have severe infection, 48 
mild infection and 165 would be asymptomatic.
If toxoplasmosis could be prevented, 1 to 2 severe infections 
per 16 500 births could be avoided. Unfortunately, there are at present 
no measures such as immunization available, and the only control measures 
advocated are the avoidance of sources of cyste (raw meat) and oocysts 
(soil contaminated with cat faeces) during pregnancy.
Screening programmes for the detection of acute toxoplasmosis 
during pregnancy would be very difficult and expensive to undertake, and 
there are many far more important diseases which should receive public 
health priority. Fortunately, the incidence of toxoplasmosis during 
pregnancy and the congenital transmission rate are particularly low 
by world standards. Until vaccination or other practicable preventive 
measures are developed, little can be dor to prevent or treat toxoplas­
mosis during pregnancy.
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1.0 REVIEW OF TOXOPLASMOSIS
1.1 Introduction 
Despite its still being considered an 'exotic1, 1 rare1 or 'tropical1 
infection, toxoplasmosis is one of the commonest infections of man and 
animals throughout the world. These infections are with the protozoan 
parasite, Toxoplasma gondii, which is found in many species of animals 
and birds. The definitive host of T. gondii is the cat family, where 
the coocldian nature cf this parasite was discovered (Cahill, 19741 .
T. gondii is the only species in the genus Toxop'-asma, and it 
takes its generic name from the Grsek 1toxon' meaning bow or arc and 
its specific name from the small North African rodent, Ctenodactylua 
gondi, which was used as a laboratory rodert by the Pasteur Institute 
in Tunis. Following the first descriptions of the parasite early this 
century, the universal nature of Toxoplasma infections has become 
apparent, and much effort has been expended throughout the world on 
investigating this parasite (Frenkel, 1971).
Since the first reports of human and animal toxoplasmosis 70 years 
ago, much has been learned about this organism, its modes of transmission 
and the diversity cf disease patterns produced in man. It has Leen 
estimated that 500 million humans have evidence of infection, and the 
fact that congenital transmission can occur, raises the problems of the 
extent of the risk of congenital infection and the possibility and 
practicality of the development of a vaccine for human use (Kean, 1972).
1.2. History
In 1908 T. gondii was described by workers in both North Africa and 
Brazil. Gondis used at the Pasteur Institute of Tunis au laboratory 
rodents for leistimaniasis research were found in 1907 to be dying of a 
new infection by Nicolle and Manceaux (1908). The organism was also 
described by Splendere (1909) in laboratory rabbits in 5ao Paulo, Brazil. 
These workers considered the parasites to be either Piroplasma or 
Leiehmania.
Also in 1908, the first probable case of human toxoplasmosis was 
reported from Panama (Darling, 1908). Parasites were observed in muscle 
biopsies, but were mistaken for Saroooystis in Darling's report 'Sarco-
sporidiosis: wlti. report of a case In man'. This case was regarded by 
Kean (1972) as being classical of asymptomatic toxoplasmosis of muscle.
In 1923, the first human case of congenital toxoplasmosis was described 
by Janku (1923) in Prague. The diagnosis was made by the observation 
of parasites in retinal sections of an infant who had microphthalmia.
Large numbers of rabbits were b.ed on the farm of this child's parents, 
and the mother had frequently eaten rabbit meat during her pregnancy.
Janku considered the parasites seen in the child's eye to be coccidia 
resembling Eimevia, a pathogen of rabbits, and that transmission had 
been transplacental.
In 1939, the first report of the isolation of the parasite by animal 
inoculation of tissues from a neonate with encephalitis was published by 
Wolf et al. (1939). Until this report, Toxoplama was considered to be 
somewhat of a nuisance in laboratory rodents used for virological 
studies, and this report firmly established the role of Toxaplaema in 
human disease. It. was also the fir it example of an infectious agent 
producing foetal disease in utero, the association of rubella with 
intrauterine infection only being considered two years later (Feldman, 
1974). Toxoplasmosis of childhood was characterised by Sabin (1942), 
and in adults by Pinkerton and Henderson (1941). Toxophzstruz retino- 
choruiditis was recognized in adults by Wilder (1952), and organisms 
first isolated from the eye by ’a obs et al. (1954). Relapsing toxoplas­
mosis due to immunosuppression was recognized in corticosteroid treated 
hamsters, and later described in man iFronkel, 1956) .
Sabin in 1942 described the first serological test for toxoplasmosis 
using inhibition of rabbit "kin necrosis by organisms exposed to sera 
containing antibodies (Sabin and Ruchman, 1942). U; 1946, the Sabin- 
Feldman dye test (Sabin anu Feldman, 1948), complement fixation test 
(Warren and Russ, 1948) and toxoplasmln skin test were described (Frenkel, 
1948).
Despite the disease in man being well characterized, the modes of 
transmission remained largely obscure until 1969, when Toxof laerna was 
recognized by Frenkel et al. (1969) as an intestinal ccccidian of cats, 
which arc the definitive hosts, with many intermediate hoeto, including 
man. This discovery followed the work of Hutchison (1967), who suggested 
that transmission occurred in nematode ova from the intestinal tract of 
cats. Although transmission was later shown to occur independently of
nematode ova, Hutchison's work led to the establishment of cats as the 
definitive host of Toxoplasma and to tne role of cats in the maintenance 
of Infection in herbivores. Evidence suggestive of oocyst transmission 
to humans was obtained in an outbreak of toxoplasmosis traced to cats in 
a horse-riding stable (Francis d>t aZ.», 1977).
Some of the above and other historical highlights of toxoplasmosis, 
modified from Frenkel (1973a), are shewn in Table 1.1.
TABLE 1.1. Highlights of the history of T. gondii and
toxoplasmosis, based on Frenkel (1973a)
1908 Discovered in gondi and rabbit (Nicolle & Manceaux; Splendorc)
First probable human case (Darling)
1923 Identified in eye of child at autopsy (Janku)
1937 Intrauterine transmission and neonatal encephalitis recognized
(Wolf & Cowan)
1942 First comprehensive review (Sabin)
1945 Cysts recognized in asymptomatic humans (Kean & Grocott)
1948 Dye test described (Sabin & Feldman)
Toxoplasmin skin test described (Frenkel)
1949 Toxoplasma retinochoroiditis in adult described fFrenkel)
1952 Toxoplasma identified in retinas of 50 human cases (Wilder) 
Glandular toxoplasmosis recognized (Siim)
1953 Synergism of sulphadiazine and pyrimethamine recognised (Eylea 
& Coleman)
1954 Toxoplasma isolated from eye with retinochoroiditis (Jacobs et at.)
1957 Fclinic acid used to counteract side effects of therapy (Frenkel
4 Hitchings)
1959 Repeated congenital transmission described in mice (Beverley)
1960 Meat suggested as important source of infection (Jacobs ; ; al.)
1965 Human infection rate increased by raw meat diet (Desmonts et al-)
1968 Cat nematode ova dissociated from transmission (Frenkel et at.,
Hutchison et al.)
1970 Sexual cycle in cats discovered (Frenkel et al., Hutchison et al.
and others)
1972 Confirmation of epidemiologic role of cats from island studies
(Wallacei Munday)
1974 Definitive information on the role of Toxoplasma in pregnancy
and the risk of congenital Infection (Desmonts & Couvreur)
1.3. Classification 
Although the taxonomic status of Toxoplaema has not been finalized, 
provisional classification Is as follows:
Phylum - PROTOZOA
Subphylum - SPOROZOA
Subclass - COCCIPIA
Family - TOXOPLASMIUAE
Genus - TOXOTLASM
Species - gcnidii
T. gondii is the only secies recognized in the genus Toxoplaema.
Other families in the subclass Coccidia include Besnottiidae and 
Sarcocystidae, and they can be differentiated as follows (WHO, 1969): 
Toxoplasmida^. Cysts with thin membranes and pseudocysts. Naked 
zoites possess a vesicular nucleus, a conoid, toxonemes and a mlcropyle 
but no flagella or cilia. Reproduction is by endodyogeny. Locomotion 
is by subpellicular fibrils.
lesnoltildae. Cysts with thick, laminated, nucleated walls and 
pseudocysts. Naked zoites, reproduction and locomotion as for toxoplas- 
midae.
Sarcocystidae. Elongated cysts, often septate and with cytophanereu. 
Elongated naked zoites possess a vesicular nucleus, a conoid, toxonemes, 
a zone of central granules, and a mlcropyle, but no flagella or cilia. 
Reproduction and locomotion as for toxoplasmidae.
1.4 Definition of terms
Terms used are based on recommendations contained in the report of a WHO 
meetlr ;« of investigators (WHO, 1969) as well as those of Zigas and 
Benfante (1972), Hoare (1972) and Jacobs (1974).
1.4.1 Tissue stages 
Endozoite (tachyzoite). The individual organism inside the pseud - 
cyst produced as the result of asexual division (endodyogeny).
Cystorolte (bradyzolte). The individual organism inside a cyst 
resulting from endodyogeny.
Pseudocyst. The collection of endozoite* within a vacuole inside 
the host cell.
Cyst. A collection of cystozoites enclosed within a tough, resiliei.t, 
dense wall laid down on the internal membrane of the host cell vacuole.
Cysts may eventually become extracellular because of distension ana
rupture of the host cells.
Endodyogeny. The production of two merozoites within the original
surface membrane of the mother organism, commencing with the formal ion
de novo of two conoids and the division of its nucleus.
1.4.2 Intestinal epithelium stages
Trophozoite. The form of parasite which grows an<f prepares for
schizogony in intestinal epithelial cells.
Schlzont. The form which produces merozoites by multiple formation
of cytoplasmic components and nuclear replication.
Merozoite. Individual product of schizogony.
Gametocyte. Precursor of male or female gamete.
Gamete. Male or female product of gametogony.
Zygote. Product of fertilization of female gamete by male gamete. 
Oocyst. Zygote with a heavy protective wall. 
gporont. Zygote undergoing division into sporoblasts.
Sporoblast. Derivative of sporont undergoing further division into
sporozoites.
Sporozoite. Product of division of sporoblast.
1.4.3 Hosts
Host. Vertebrate susceptible to infection with T. gondii.
Definitive host. Host in which sexual reproductive cycle occurs
in intestinal tract.
Intermediate host. Host in which only asexual reproductive cycle
occurs in extra—intestinal tissues.
Apparent host. Animal in which T. gondii produces a clinical syndrome.
Dead-end host. Kan, who does not usually serve as a source of
infection for other animals.
1.5 Parasitology
1.5.1 Morphology
T. gondii proliferative forms (endozoiteel under the light microscope 
resemble those of other Sporozoa. However, unlike other Sporozoa which 
are host-specific, Toxoplasma is capable of parasitising not only a wide 
range of hosts but also a wide range of organs and cell types in these 
hosts. Like other Sporozoa, Toxoplasma has a sexual cycle in a definitive 
host, which for Toxoplama is the cat family (Frenkel, 1970).
The form of T. gondii found during the acute infection of a host is 
a slender, arc-shaped endozoite, 2 to 4 ym wide and 4 to 7 ym long, with 
one end more tapered than the other. It can move slowly with its narrow 
anterior end describing a circular motion, and resembles a merozoite of 
malaria when stained with Giemsa. A reddish nucleus and light blue 
cytoplasm with occasional cytoplasmic granules can be seen.
Electron microscopy shows a complicated system of organelles. The 
parasite is enclosed in a double-unit membrane. The inner membrane is 
continuous except for a slight thickening called the polar ring which 
surrounds the conoid at the anterior end and a similar thickening at the 
posterior end. Fibrils extend longitudinally between these thickenings 
and are probably responsible for the gliding movements of the parasita. 
Within the anterior polar ring is the conoid, a conical organelle made up 
of tubules wound in a spiral. The posterior end of the conoid appears 
open, and 4 to 8 paired organelles called toxonemes extend posteriorly to 
the Golgi body just anterior to the nucleus. A number of micronernes also 
extend posteriorly from the conoid to the nucleus. The nucleus is in the 
posterior half of the organism, surrounded by a double membrane with 
pores in it. The cytoplasm contains rough endoplasmic reticulum, free 
ribosomes, mitochondria and glycogen vacuoles. At the level of the 
anterior end of the nucleus is a micropyle which may function as a cyto- 
stome (Jacobs, 1974). A diagramatic illustration of the organism is 
shown in Fig. 1.1.
1.5.2 Life Cycle
Toxoplasmic phase; T. gondii endozoltes reproduce by a process called 
endodyogeny, originally described by Goldman et (ll, (1958) as an internal 
budding process. Two cones of heavily staining material consolidate near 
the nucleus, and 2 new nuclei form underneath these cones. Eventually 
the cones and daughter nuclei are surrounded by new cell membranes and 
break out of the nu ten.al cell, destroying it. This process resembles 
the type of reproduction seen in Sporozoa, and is considered to be a 
special form of schizogony called endodyogeny in wnich onl” 2 progeny are 
formed.
In chronic Infections, organisms persist for years as cystozoites in 
cysts. The cyst wall is a dense matrix of mater'll originally deposited 
on the inner membrane of the host cell vacuole containing the parasites. 
Rough endoplasmic reticulum and mitochondria of the host cell are concen-
p Polar ring
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T "loxonemes
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ER Endoplasmic
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1 Schematic diagram of the electron microscopic morphology 
of Toxoplaema gondii showing intracellular organelles.
trated outside the vacuole and may contribute to the cyst wall substance. 
The cyst wall substance eventually extends between multiplying parasites, 
and becomes a true parasitic cyst. Organisms within a cyst continue to 
reproduce by endodyogeny, but more slowly, and cynts car4 reach sizes of 
100 ym or more in diameter. Cyst development is independent of the 
host’s immune response. Cystozoites are resistant to digestion by gastric 
juice, r.iereas proliferative forms of vrganisms derived from infections in 
the acute phase aro immediately destroyed by gastric juice. Cysts dissolve 
rapidly in gastric juice, but the cystozoites released are capable of 
survival for up to 3 hours.
Within its many hosts, T. gondii proliferates intracellularly in 
almost every organ. Parasites may appear briefly free in the blood, and 
may later appear in leukocytes. In chronic infection, cysts may be 
demonstrated in brain tissue, skeletal, cardiac and smooth muscle, and 
in various other organs.
After ingestion, cyst digestion occurs in the stomach with the 
release of gastric juice-resistant forms which can invade the intestinal 
upithelium. In animals other than the cat family, endodyogeny occurs, 
fhile in felines both endodyogeny and schizogony can occur.
:sosporan Phase: The development of intestinal forms proceeds in the
epithelium of the feline 1 \1unum, ileum and colon, in 2 stages - asexual 
development and garnetogony (Jacobs, 1974).
Asexual Development: This starts from 12 hours aftt cyst ingestion
»nd continues for up to 15 days. Organisms penetrate intestir 
epithelial cells, grow and become rounded trophozoites which *y
into schizonte containing 4 to 24 merozoites. The formation ot cytoplas­
mic elements lags behind nuclear division in this process. Merozoites 
are released from host cells and can re-invMe new cells and repeat the 
progress of schizogo The number of generations of merozoites produced 
is unknown.
Sexual Development - Gametoqony then occurs with the invasion of host 
cells by merozoites which develop into micro- and macrogametocytea. 
Microgametogony occurs with nuclear multiplication; each nucleus migrates 
into surface protruberances in which 2 flagella develop from a basal body. 
Six to 32 microgametocytes are produced. Microgametocyt.es are 3 to 5 ym 
long with flagella 6 to 10 ym long. Ma- rogametocytes are produced from 
rerozoites, and are 13 ym in diametei when matur .
Microg&metocytes are released into the intestinal lumen with 
fertilization of macrogametocytes in the imall bowel epithelium. After 
fertilization, thf zygote lays down the oocyst wall and sporogony begins. 
The oocyst is shed unsporulnted, and measures 10 by 12 urn. After a 
period in the environment, 2 sporoblasts form, which develop into 2 
sporocysts each containing 4 sporozoites.
After ingestion of Toxoptav.-na cysts by a cat, oocysts are shed after 
a prepatent period of 4 to 5 days, and shedding occurs for 9 to 20 days. 
After ingestion of endozoites the prepatent period is 5 to 19 days, and 
shedding occurs for 2 to 12 days. Cats are relatively resistant to 
infection with oocysts, and large numbers ire required to prodice 
infection. Prepatent period with oocysts is 21 to 49 days, and shedding 
occurs for 5 to 8 days (Wallace, 1973).
As well as the domestic cat, the bobcat, ocelot, jaguarundi, cougar 
and Asian leopard have been shown to shed oocysts. Oocysts are infectious 
to many species of animals and birds, and probably account for infection 
of herbivores (Frenkel, 1973a).
Toxoplaoma appears to represent the development from the usual one- 
host coccidium to a two-host cycle. Infection can be perpetuated by 
carnivorism, with only the toxoplasmic phase of reproduction occurring.
The life cycle of T. gondii is shown schematically in Fig. 1.2.
The isosporan phase of asexual development and gametoqony has only 
been described in the gut of cats, and is host specific (Frenkel, 1971). 
However, two other intestinal coccidia of cats, ieoepora felie and J. 
rivolta have also been shown to infect extra-intestinal tissues in cats 
and to parasitise extra-intest nal tissues of rodents (Frenkel and Dubey, 
1972). The life-uycle of Toxoplasma is certainly not unique among 
the coccidia, and strengthens its inclusion in this subclass of Sporozoa.
1.5 3 Transmission 
Toxoplasma appears to have originated as an intestinal coccidian of cats, 
with faecal-oral transmission. The formation oJ persisting cysts in 
tissues such as brain and muscle has made it posi-’ble for carnivorism to 
become an additional means of transmission. Animals ard birds can become 
infected by eithar oocysts or cysts, the cat being the definitive host, 
while other animals and birds are facultative intermediate hosts 
(Frenkel, 1971).
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tig. 1.2. Life cycle of Toxoplasma gondii , showing isospo >nase 
which only occurs in felines and toxoplasmic c which 
occurs in all animals and in birds. Intrace_*uiar stages 
are in circles and resistant stages are in shaded circles.
CarnIvorism. This appears to be an important mode of transmission. 
Toxoplasmosis has been shown to be rapidly acquired in institutions 
serving undercooked beef or horse meat, and an epidemic of toxoplasmosis 
from eating undercooked hamburgers was described by Kean et al. (1969) in 
New York. In this outbreak five students who all ate rare hamburgers at 
the same place and at the same time developed acute lymphadenopathic 
toxoplasmosis with high and rising Sabin-Feldman dye test titres and 
positive complement fixation tests. The meat involved was ground beef 
which could have been contaminated with pork. The incubation period in 
this outbreak was 8 to 13 days, and the patients presented with fever, 
rash and lymphadenopathy. A further 24 seronegative students who ate 
hamburgers at the same time did not become infected, either as their meat 
was adequately cooked or the number of cysts was scanty or irregularly 
distributed. In France, institutionalized children fed undercooked beef or 
mutton for therapeutic purposes seroconverted at a very high rate, indica­
ting these as sources of infection and probably providing the explanation for 
the high seropositivity rate in France (Desmonts et al., 1965a).
Transmiss* . by earnivorism appears to be due to ingestion of cysts from 
chronically infected animals, and pork and mutton appear to be infected 
more frequently than beef (Jacobs, 1967, Work, 1971). T," prevalence of
Toxoplasma antibodies in sheep varies, with a maximum of 90 percent positives 
in Yorkshire, England. In swine, 11 to 66 percent have been found to be 
seropositive, and up to 50 percent of cattle are seropositive, cattle tending 
to have lower titres. Digestion of skeletal muscle samples from animals 
with artificial gastric juice and subsequent mouse inoculation has resulted 
in isolation of Toxoplasma from sheep and swine in many parts of the world. 
Beef is less 1 y to contain Toxoplasma cysts, but the epidemic reported 
by Kean et al. (1969) was probably transmitted via beef.
The oocyst is now known to be the method of transmission 
from cats. Hutchison (1967) first transmitted the infection from cat 
faeces in the presence of ova of Toxooara oati , in which he thought the 
Toxoplasma was transmitted. In 1969, Frenkel et al. (1969) separated Toxo­
plasma from Toxocara, and in 1970 several workers described the oocvat of 
T. goruiii and demonstrated it to be the infective form of this parasite
(Frenkel, 1973a). Oocysts are infectious to all animals and survive passage 
through the stomach.
In 1977, one of the largest outbreaks of acute toxoplas <iosis in the 
USA occurred in Atlanta, Georgia, and further evidence of direct trans-
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mission from cats to man via oocysts was postulated (Francis et o Z I  
1977). In this outbreak, 29 riding-stable patrons developed fever, head­
ache and 1ymphade;lopathy over an 6-week period, and 28 showed serological 
evidence of acute toxoplasmosis. Five asymptomatic infections were also 
diagnose Logically. Cats from the stable were bled, and ? out of
3 were sei lltlva, Transmission was thought to be by inhalation or 
ingestion c l - c y s t s  from cat faeces in the extremely dusty conditions 
in the riding r (balls, 1978).
Transplacental: Thi.; first recognized in man (tiabin, 1942), and
has also been observed in mice, rats, guinea pigs, dogs, sheep and mink. 
Transplacental spread in man usually only occurs if primary maternal 
infection occurs during pregnancy. Discussion of the importance of this 
method of spread is presented in Chapter 2.
Accidental; Laboratory workers have bacome infected after accidental 
needle inoculation or splashing infective material into the eyes (Frenkel, 
19/3b).
Organ transplantation and blood transfusion; Occasional cases have 
been described, mainly in immuno-suppressed donors or recipients (Frenkel, 
1973b).
Role of arthropods: Various arthropods have been shown to be capable
of mechanically transmitting oocysts on their feet or disseminating 
them after ingestion, but their role in transmission is considered to 
be minor vFrenkel, 1971).
Birds and eggs: Chicken eggs have rarely been found to be infected
with Toxaplaema, and organisms can be Isolated from the ovary and 
oviducts of hens (Jacobs and Melton, 1966). Th> meat and eggs of birds, 
eaten in some Alaskan communities, may be a source of human infection 
(Peterson et al- p 1974).
Milk: Organisms have been isolated or transmitted from milk in
mice, cows, pigs, dogs, cats, goats, guinea pigs, rabbits and sheep 
(Frenkel, 1973b) Infected milk may oc isicnully transmit toxoplasmosis 
in animals, but pasteurization will destroy all forms cf the organisms 
(Frenkel, 1973b).
Other: Whether additional methods of transmission occur and are
important, especially in man and herbivores, is still unknown. Feldman 
(1974) has stated that 'after we have consi-h •od meat nd its, we are 
left with a large, if not major, proportion of human infections which are 
unexplained'.
1.6 Resistance of Toxoplasma to physical and chemical agents 
The ability of T. gondii to survive in the environment is of critical 
importance with regard to its spread. In studies conducted by Work 
(1971), naturally infected pork was studied. He found that normal 
cooking procedures such as frying and roasting as well as slight salting 
and low temperature smoking killed cysts. Freezing at ~20°C for 24 
hours was also sufficient to kill the cysts. Ir. the animals studied, 
all parts of the rc.w carcass were infective. Tasting of raw meat during 
food preparation by Kvsewives is thought to he important in transmis­
sion from infected aiiim«ic
Survival of Toxoplasma endozoitvs and cysts has been studied by many 
workers, and details are shown in Table 1.2 (Work, 1971). Oocysts are 
the most resistant forms, but heating to over 45°C, as well a_, drying, 
formalin, ammonia and iodine will kill oocysts or prevent them from 
sporulating and becoming infectious (Frenkel, 197.3b) .
1.7 Pathology
The range of infections caused by T. gondii varies from asymptomatic to 
fatal. Factors contributing to pathogenicity include the capacity to 
invade cells and to persist causing c.ironic infection. Toxoplasma is 
capable of infecting most nucleated cells, including nucleated red cells 
of birds. The parasite can multiply after invading cells as well as 
after being phagocytosed. Dissemination occurs directly from cell to 
cell, via the blood stream and lymphatics, via serosal spread and in 
monocytes and macrophages (Frenkel, 1971).
The effects of infection vary with age - asymptomatic infections occur 
in adult rats and chickens, but baby rats and chick embryos are extremely 
susceptible to infection. Mice, hamsters and rabbits usually develop 
overt disease. In man, the most severe effects of infection are produced 
in the foetus.
Acquired immunity to Toxoplasma
With the development of humoral and cellular immunity to infection, a 
state of premunition is reached, with the persistence of cysts for years. 
Immunity results in a striking reduction in the numbers of parasites, and 
mononuclear cells appear to develop a specific capacity to digest Toxo­
plasma. Antibody assists in lysis of extracellular organisms in the 
presence of the accessory complement-activating (properdin) system.
Human sera lacking any of complement factors C5 tr C8 also lack this
T A B L E  1 . 2 .  S u r v i v a l  o f  Toxoplaama e n d o z o i t e s ,  c y s t s  a n d  o o c y s t s
Endozoites Cysts
Heat
Freezing
Osmotic
changes
-
Killed by 10-15 
mina at 50°C
Survive for up to 
200 days at -70°C 
in 5-10% glycerol
Survive for up to 
18 days in skim 
milk
Killed by water 
after 30 mine at 
37°C. Survive 30 
mins in saline
0.2-5% at 37°C
Killed in 2h hrs 
at room tempera­
ture
Killed in 10 mins 
by 70% alcohol 
and 5% phenol
Gastric
juice
Household
cooking
Killed in 30 mins
Killed by 10 
mins at 60°C 
or 1 hour at 
50°C
Usually killed 
by -15°C for 
24 hrs
Survive for 
to 68 days
up
Killed by water 
after 30 mins
Killed after 1 
day at 18-20°C
Oocysts
Killed by 60°C for 
10 mins
Survive freezing at 
-21°C for more than 
4 weeks
Survive
Survive
Survive for 
2-3 hrs
Killed by normal 
procedures
Killed
Resistant to 2% sul­
phuric acid, sodium 
hypochlorite (24 hrs), 
and 10% formalin (6 
hrs). Destroyed after 
24 hrs by 10% formalin 
and in 10 mins by 10% 
ammonium hydroxide and 
7% iodine
Survive
activator activity (Feldman and Schr.lh.r, 1970,. However, antibody doe. 
not effect intrecellul.r multiplication, end vlde.pread dlesemlnation can 
occur in immunoeuprree.ad per.cn. and animal, with chronic infection, and 
the main defence against Toxoplasma is cell-mediated inmunity.
Hypersensitivity
Delayed hypersensitivity can occur in toxoplasmosis with release of anti­
genic material in chronic infection, leading to exaggerated necrosis and 
Inflammatory response. Delayed hypersensitivity is Important in som 
manifestations of disease due to toxoplasmosis, such as retinoohoroiditis.
Virulence
Strains of Toxoplasma show marked differences in virulence or relative 
pathogenicity in a single species, and this may change with host 
adaptation. Virulence in one species does not necessarily correlate 
with virulence in another species, and differences in strain virulence 
in different parts of the world are difficult to assess (De .toever- 
Bonnet, 1966).
Mice have often been used to study the virulence of strains, but do 
not provide much information as they are highly susceptible to infection. 
Different strains of mice have marked differences in susceptibility to 
infection (Araujo et al.t 1976) and a strain of mouse highly susceptible 
to Toxoplasma has been reported (Kamel et al.t 19/0).
1.8 Clinical Features of Toxoplasmosis in Man
1.8.1 Acute a< c[. ired toxoplasmosis 
The prevalence of Toxoplasma antibodies increase with increasing ege, 
indicating that the majority of cases of t,toplasmosis are acquired.
The ma ority of these infections are completely asymptomatic, but a small
number of cases present clinically.
Features of acute toxoplasmosis are not characteristic or pathog­
nomonic , and may mimic commoner diseases. Described features include 
lymphadenopathy, myocarditis, pericarditis, hepatitis, encephalitis, 
pneumonitis, myalgia, arthralgia and maculopapular rash. These features 
often lead to an incorrect diagnosis, and toxoplasmosis as the diag­
nosis is either rarely considered (Remington, 1974) or is over-diagnosed 
in patients with serological evidence of past Infection.
The lymphadenopathic form ot infection is the commonest clinical 
manifestation of toxoplasmosis, and has been recognized in many parts 
of the world. Ibis presentation can mimic infectious mononucleosis 
with generalized lymphadenopathy, and hepatomegaly and splenomegaly may 
occur. Lymphocytosis can occur and atypical lymphocytes may be detected 
in acute toxoplasmosis. Lymphadenopathy may also be localized, often 
being cervical only. Toxoplasmic lymphadenopathy results in a charac­
teristic and almost diagnostic histopathologic picture originally 
described by Pirlnger-Xuchinka (1952).
Treatment of immunologically normal persons with toxoplasmic lympha­
denopathy is rarely indicated as this fcrn> of infection is self-limited 
and has no untoward sequelae (Remington, 1974).
In a recent analysis of 100 cases of the glandular fever syndrome 
of fever, lymphadenopathy and pharyngitis (Paublini, et al, 1977), 65 
cases were found to be due to infectious mononucleosis, 22 caused by 
T. gondii and 13 by cytomegalovirus. Differentiating features of these 
infections were assessed. Throat involvement was prominent in Infectious 
mononucleosis and toxoplasmosis but not in cytomegalovirus. Pyrexia 
was uncommon in toxoplasmosis, and hepatomegaly and splenomegaly 
less prominent. Liver function tests were usually normal in toxoplasmosis 
and abnormal in the otner two conditions. Lymphocytosis and atypical 
lymphocytes were commonly found in infectious mononucleosis and cyto­
megalovirus but rarely present in toxoplasmosis.
1.8.2 Recrudescent toxoplasmosis in the compromised host 
Together with certain fungi, Gram-negative bacteria, DNA viruses and 
Pneumocystis oarinii, Toxoplasma is an important pathogen in patients 
with impaired immunologic mechanisms (Remington, 1970). Host resistance 
can be compromised either by underlying diseases such as malignancies 
and/or by therapy with corticosteroids and cytotoxic agents. This form 
of infection has been reported in leukaemias, Hodgkin's disease, multiple 
myeloma and other lymphomas, as well as in other malignancies. Cases 
have also occurred following renal and cardiac transplants (Remington, 
1970).
The predominant features of recrudescent toxoplasmosis are necro- 
tiaing encephalitis, myocarditis and pneumonitis. These infections are 
life-threatening and potentially treatable, and it is therefore important 
to establish the diagnosis as early as possible. Most patients had had 
their malignancy for more than a year, and usually had received extensive 
therapy with cytotoxic agents, steroids and irradiation. Features of 
to-oplasmic encephalitis are coma, himiparesls, headache, drowsiness, 
disorientation, cranial nerve palsies, papilloedema and convulsions.
Fever is often present, and less commonly rasn, myocarditis, pneumonitis 
or lymphadenopathy may be associated. Cerebrospinal fluid studies have 
shown elevated protein levels with up to 100 mononuclear cells per yl. 
Electroencephalograms are usually abnormal, showing diffuse slowing and 
disorientation. Treatment is effective in arresting the disease, and 
intraventricular pyrimethamine has been used in a few cases with apparent 
success. Many iramunosuppressed patients with recrudescent toxoplasmosis 
have concurrent cytomegalovirus or herpes fimplex virus infections, and 
the prognosis in such cases is extremely poor (Vietzke, et al., 1968).
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An interesting case of chronic lymphadenopathic toxoplasmosis was 
reported by Sheagren et al. (1976). An 18-year old patient developed 
recurrent Toxo]'laama lymphadenitis, and T. gondii was isolated from 
lymph nodes on each occasion over a 6-year period. During successive 
recurrences, the patient showed generalized energy to cell-mediated 
immune stimuli. This patient subsequently was diagnosed as having 
Hodgkin's disease, and the depression of his ceil mediated immunity 
was reflected in both his cell mediated anergy to skin test antigens 
and his prolonged Toxoplaema infection.
Treatment if begun early enough can prove lifesaving, and recommended 
treatment is a loading dose of 100 to 200 mg pyrimethamine in divided 
doses on the first day, followed by 25 mg daily for at least one month, 
combined with 6 to 8 g sulphadiazlne or triple sulphonamides daily after 
a loading dose of 4 to 6 g. Folic acid and/or yeast may be given to 
protect the bone marrow (Remington, 19741.
1.8.3 Ocular toxoplasmosis 
Since Janku's discovery of ocular toxoplasmosis (Janku, 1923), much has 
been done to clarify the pathogenesis of this form of Toxoplaema 
infection. The characteristic feature of ocular toxoplasmosis is the 
atrophic pigmented retinal scar of focal necrotising retinitis (O'Connor, 
1974).
Toxoplasmic cysts are known to occur in the retinas of chronically 
infected persons, but spontaneous breakdown of such cysts has not been 
observed in man, and recurrent retinal lesions are thought to be the 
result of the multiplication of organisms and not the result of antigen 
release from cyst rupture (O'Connor, 1974). Lapses in cell-mediated 
immunity may permit proliferation of parasites in the retina and else­
where, resulting in recurrent retinochoroiditis.
Anterior uveitis can also be caused by Toxoplaema, presumably from 
the release of antigens into the intraocular fluids. The iris and 
ciliary body are infiltrated by lymphocytes and plasma cells with release 
of proteins into the anterior chamber. Recurrence of posterior uveitis 
(retinochoroiditis) can stimulate an anterior reaction, but anterior 
uveitis can occur in the absence of posterior uveitis, possibly due to 
circulating antigens or immune complexes released from distant sites.
Ocular toxoplasmosis Is a manifsstation of both congenital and 
acquired infection, although some workers feel that many cases in adults
are the end result of previously asymptomatic congenital infection 
(Perkins, 1973). However, 9 well documented cases of acquired retino- 
choroiditis have been reported (Masur et at., 1978).
The diagnosis of ocular toxoplasmosis depends on finding a morpho­
logically acceptable lesion, on obtaining a positive serological result 
and on excluding other infective causes. The characteristic lesion is 
a focal necrotising retinitis. In the acute stage, the lesions appear 
as yellowish-white, cotton-like patches in the lundus. They are usually 
in small clusters, and exudate may be cast off obscuring the fundus. 
Retinal oedema is commonly obser sc, and oedema of the macula is present 
if lesions occur above the macula. The optic nerve can be involved, and 
lesions can result in segmental atrophy of the nerve. Peripheral 
retinal lesions can also occur.
In anterior uveitis, cells, protein and keratic precipitates are 
found in the anterior chamber, with posterior synechiae and nodules on 
the iris. Posterior uveitis is almost always present.
The clinical picture of ocular toxoplasmosis is virtually specific, 
but serum antibody titres are often very low, and the titre bears no 
relation to the activity or th* ocular disease (O'Connor, 1974). Any 
dye test (or equivalent test) titre is significant in the presence of 
characteristic ocular lesions, even if titres a n  below those generally 
considered significant.
In atypical cases, precipitating antibodies can be detected in 
anterior chamber fluid. Other causes of necrotising retinochoroiditis 
such as syphilis and tuberculosis should be excluded.
Pyrimethamine and sulphcnamldes have produced disappointing results 
.n the treatment of ocular toxoplasmosis, but are often effective in 
early lesions. Treatment rarely affects chronic elevated lesions. If 
lesions are a threat to vision or likely to result in retinal detachment, 
oral corticosteroids should be given with pyrimethamine and sulphcna- 
mldes. Sulphonamldes or tetracycline with corticosteroids may be used 
if pyrimethamine camu t be tolerated or causes haemopouitic depression. 
Steroids should never be given alone (O'Connor, 1974).
Clindamycin has been shown to be effective in experimental ocular 
toxoplasmosis in rabbits (Nozik and O'Connor, 1968), but no human 
studies have been performed. Local and intravenous BCG has also been 
effective in limiting experimental ocular toxoplasmosis, but awaits human 
trial (O'Connor, 1974).
1.8.4 Congenital toxoplasmosis 
The foetus is infected in utero during acute maternal toxoplasmosid, 
and organisms reach the foetus from the placenta via the umbilical vein. 
Lesionr. are usually more severe in the immunologically immature infant 
than in the mother, and infection remains active lonoer. Encepha­
litis, retinochoroiditis and hepatitis characteristically occur. 
Intreventricular dis. «*mination of the organisms may occur leading to 
hydrocephalus from obstruction of the aqueduct. Periaqueductal and 
periventricular necrosis occur as a result of antigen-containing 
vantricular fluid coming into contact with blood vessels carrying anti­
body and resulting in immune complex reactions (Frenkel, 1974) . These 
lesions produce the characteristic clinical features of classical 
conger ital infection.
The classical triad of retinochoroiditis, hydrocephalus and intra­
cranial calcification was originally described by Wolf et al. (1939). 
However, clinical features are extremely variable, and the diagnosis 
should be considered in a wide range of neonatal a^d infantile ill­
nesses (Eichenwald, 1959). Table 1.3 summarises these findings in 152 
clinically affected cases. Two types of diseases were described, the 
neurologic type being more common, while the generalized type occurred 
less frequently but was recognized earlier in life, usually in the 
first month.
TABLE 1.3. Signs and symptoms occurring in 152 i'Z^bs of clinical 
congenital toxoplasmosis reported oy Eichenwald (1959)
Type of disease;
Neurologic 69%
Generalized 28%
Retinochoroiditis 80% Pneumonia 21%
Abnormal spinal fluid" 69% Diarrhoea 16%
Anaemia 64% Hydrocephalus 14%
Splenomegaly 56% Rash 13%
Jaundice 54% Hypothermia 11%
Fever 51% Eosinophilia 11%
Hepatomegaly 47% Abnormal bleeding 11%
Lymphadenopathy 43% Microcephaly '%
Convulsions 34% Glaucoma 1%
Vomiting 32% Optic atrophy 1%
Intracranial calcifi­ MicrophthaImia 1%
cations 27%
* Lymphocytosis and/or raised protein level
Retinochoroiditis was the commonest finding, Lut only occurred with 
hydrocephaly and intracranial calcification in about a quarter of 
cases. Many features such as anaemia, splenomegaly, jaundice and 
lymphadenopathy are too nonspecific to be useful diagnostically. Four 
of Eichenwald's cases were asymptomatic at birth, but two developed 
severe neurological diseas'* later (Eichenwald, 195 j) .
Subclinical or very mild infection appears to be much more frequent 
than symptomatic infection. Twenty to thirty percent of infants born 
with congenital infection have severe disease, 10 percent have ocular 
involvement only, and the remaining 70 percent are asymptomatic iAlford 
et al., 1974).
Screening for congenital toxoplasmosis is best achieved by deter­
mining cord blood total IgM levels and Toxoplasma IgM-IFA tittes.
Premature delivery was associated with 50 percent of cases. Cerebro­
spinal fluid abnormalities were prominent, with lymphocytosis and dis­
proportionately elevated protein levels. These abnormalities persisted 
for up to 4 months even In cases with less severe forms of infection, 
and I.Q. development was impaired (Alford et al., 19741.
Treatment of congenital toxoplasmosis should be given in view of 
the central nervous system sequelae cf infection, even though the 
efficacy of treatment is uncertain. Pyrimethamine and sulphadiazine 
should be used, although spiramycin may be useful. Treatment scnsdules 
are:
Pyrimethamine - 1 mg/kg/day given at 12 hourly intervals. Maximal 
dose 25 mg/day. Dosage may be halved after 4 days and maintained for a 
month. Dosages may be doubled in severe ases. Can be given orally or 
intravenously.
Sulphadiazine or multiple sulphonami - lOO-lBO mg/kg/day given
6 hourly for 1 month.
Blood and platelet counts should be monitored twice weekly and 
folinic acid supplements given to minimise toxicity due to folate
antagonism.
1.9 Diagnosis of Toxoplasmosis Kg,
Diagnosis depends on demonstration of organisms or cysts in blood, 
sputum, cerebrospinal fluid or tissues, isolation of organisms, by 
culture in animals or in tissue cultures, and on serology Serology 
is tl a mainstay of diagnosis as material and techniques for demonstration 
and isolation of organisms are not readily available.
1.9.1 Demonstrations of organisms 
Endozoites are occasionally r.een in peripheral blood smears inside 
mononuclear cells, and cysts may be seen in biopsy or autopsy material, 
particularly in muscle and brain tissue. Organisms and cysts seen must 
be identified as Toxoplasma by special stains, electron microscopy or 
direct fluorescent antibody staining. Organisms are difficult to dis­
tinguish from Sarooayetis, Besnoitia, Noaema and some yeasts, and pollen 
and fungal spores can be mistaken for cysts (Frenkel, 1971). Direct 
fluorescent antibody testing must oe adequately controlled to avoid 
false-positive reactions (Frenkel and Piekarnki, 19/8).
1.9.2 Diagnosis of Toxoplasma lymphadenitis 
During acute toxoplasmosis with lymphadenopathy, lymph node biopsy is 
not uncommonly performed to exclude a lymphoma. The distinctive histo­
pathologic changes that occur in toxoplasmosis are well recognized, 
following the original description of this picture by Piringer-Kuchinka 
(1952). Lymph nodes are only moderately enlarged (10 to 20 mm in 
diameter), the capsVt nay be slightly thickened and is usually infil­
trated by histiocytes and lymphocytes. The basic lymph node architec­
ture is retained, and the peripheral sinus is usually distended. 
Lymphocytes, macrophages, some polymorphonuclears and cells resembling 
monocytes pack the peripheral sinuses. Lymphoid follicles are enlarged 
and irregular and have prominent reaction centres with plentiful mitoses 
and phagocytosed nuclear debris. The characteristic feature is the 
presence of numerous clusters of epithelioi4 cells. These cells are- 
scattered throughout the nodr but are roort on «t the periphery of
the node. Individual cells arc eosinophili with ill defined borders 
and vesicular nuclei with clear nucleoli. Cell? may phagocytose 
nu ear debris. Giant cells do not 'ur, necrosis is rare and 
caseation has not been seen. The su. artaries in the node are enlarged
by endothelial swelling (Harrison, 1966).
These histopathologic features correspond remarkably with the level 
of dye-test antibodies and the presence of IgM-IFA antibodies. Dye test 
titres are greater than 1:4096 in over 90% of cases of ToxopiMsm 
lymphadenitis, and the IgM-IFA is positive in 97% of cases. These 
features should enable a confident histopathological diagnosis of acute 
toxoplasmosis, and e mphasises the need for clinicianc to consider toxo­
plasmosis in the differential diagnosis of lymphadenopathy (Dorfman and 
Remington, 1973).
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1.9.3 Isolation of I'oxoylaenk:
Material suspected of containing Toxoplasma, such as blocd, cerebrospinal 
fluid, and tissues such as lymph nodes, placenta, muscle and brain, can 
be used for isolation. Isolation can be attempted in animals and in 
tissue culture, although the success of tissue culture is much poorer 
(Abbas, 1967). For animal inoculation, tissue may be ground and if 
necessary trypsinized. Mice, hamsters or rabbits can be used, and 
material is inoculated intraperitoneally. Passage of peritoneal washings 
and brain may be necessary to obtain enough organisms for diagnosis, and 
animals may be monitored for seroconversion. Cysts may be <5 itrated
in the brains of seroconverters, and their identity must be ..iirme 1.
Pre-treatment of animals with steroids facilitates isolation. The 
identity or presence of oocysts in cat faeces may be demonstrated by 
mouse inoculation after sucrose gradient centrifugation and allowing 
time for sporulation (Frenkel, 1971).
1.9.4 Serological diagnosis
The Sabin-Feldman dye test is the classic reference serologic tost.
Dye test antibody appears within 8 to 10 days of infection ir. man, and 
titles reach Is 1000 or higher within a few weeks . Sera must be inacti­
vated for 60 minutes at 56°C. The test depends on the observation that 
antibcdy-coated live organisms, in the presence of accessory factor, 
undergo partial cytoplasmic lysis which can be seen under phase contrast 
microscopy. Methylene blue stains the cytoplasm, and loss of cytoplasm 
leaves nothing to be stained by the dye. The test is regarded as posi­
tive when there are more than 50 percent unstained parasites in the 
preparation. A micromodification of the test has been described, and 
this generally gives 4-fold higher titres than the original method. The 
dye test has the majcr disadvantages of requiring live organisms, and acces­
sory factor, which can be obtained from seronegative humans or gerbils 
(gerbils have 1 tan found to provide a good source of accessory factor by 
the Tropical Disease Department of the South African Institute for Medi­
cal Research). During acute infection, titres can reach very high levels 
(greater than 1:16 000), and litres gradually fall to low stable titres of 
1:16 to 1:64, at which level they can remain positive for life. Patients 
with chronic toxoplasmosis may have high or low ti4res, and sera should 
be tested from a 1:2 dilution rather than the conventional 1:16. No non­
specific reactions or cross-reactions have been observed in inactivated 
human sera (Frenkel, 1971).
The indirect fluorescent antibody (IFA) test has been applied very
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successfully to the serology of toxoplasmosis. This method does not 
require live organisms or accessory factor and can be performed with 
commorcially-available killed organisms and anti-human fluorescein- 
labelled conjugates. Titres agree well with those obtained in the dye 
test and sensitivity and specificity of these techniques compare well. 
The availability of commercial lyophilized organisms and reference 
sera has enabled the IFA technique to become the standard method in 
many laboratories (Remington, 1970). False positive reactions in the 
IFA test can occur in patients with antinuclear antibodies (Araujo et 
al., 1971). The immunofluorescence pattern in such false positive 
tests is indistiuguishable from true positives, and is not abolished 
by absorption vf sera with Dl'A. The antibodies causing false positive 
reactions are thought to attach to nuclear antigens cf T. gondii 
(Araujo ez al., 1971). Another problem in the IFA test is polar 
staining caused by nonspecific IgK antibodies (Renterghem and Nimman, 
1976; Hobbs at al., 1977).
The IFA tast has been adopted for the demonstration of IgM anti- 
Toxoplaama antibodies (IgM-IFAl based on the work of Remington (1970). 
This technique uses fluorescein-labelled anti-human IgM conjugates, 
and is useful in distinguishing maternal IgG from foetal IgM in sus­
pected cases of congenital toxoplasmosis at birth. Unfortunately, the 
IgM-IFA test has several technical difficulties. Many commercially 
available anti-human IgM conjuga^ns do not work well and are not 
standardized, and many contain anti-IgG giving false positive results.
At present, readily available standardized reagents for IgM-IFA are 
still not available ( A l f o r d al., 1974). Another limitation of
this test is that IgM antibody can persist for more than three years,
although this is not common (Remington, 1970).
The indirect h'emagglutinatlon (IHA) test described by Jacobs and 
Lunde (1957) in general also gives similar results to the dye test, but 
tends to give more positives and higher titres, and its use is usually
restricted to survey work or testing of animal sera when other methods
are not available. This test is now available commercially fiom several 
sources, and will be useful if other methods cannot readily be used.
The complement fixation test (CF*T) becomes positive later than the 
dye, IFA and IHA tests, and titres reached are low (1:8 to 1:128). The 
CFT usually only remains positive for 6 to 2d months, and generally
indicates recent infection if positive. However, the CFT can remain 
positive for several years. Antigen for this test can be prepared from 
peritoneal exudate from mice cr from infected chick embryos. The CFT 
generally reflects IgM antibodies, and is generally positive in parallel 
with the IgM-IFA test. Problems associated with the CFT are the 
possibility of sera being anti-complementary or giving false-positive 
reactions, and the difficulty in obtaining antigen of good quality 
commercially. A positive CFT in a child of between 2 and 24 months of 
age is particularly useful in supporting a diagnosis of congenital 
toxoplasmosis (Kean and Kimball, 19771.
Various immunoenzyme methods of antibody detection have been described 
using enzyme activity to read the test instead of fluorescence of fluore­
scein in the IFA test. One example is the use of peroxidase-conjugated 
antisera instead of fluorescein-conjugated antisera in the IFA test.
Slides are stained for peroxidase activity with 3-3-diamino-benzidine 
tetrachloride in the pi erce of hydrogen peroxide, and in e positive 
result the parasite is st lined brown with a dark outline. In one study, 
the immvnoperoxidase method compared well with the dye test and IFA test, 
but has the same possibility of false-positive reactions due to anti- 
nuclear antibodies as does the IFA test (Patramanis et al., 19731.
Another premising immunoenzyme technique is the enzyme-linked immuno­
sorbent asouy (ELISA) which has been applied to ToxcpLaoma in microplate 
form (Vollev et al., 1976), and adapted to detect IgG and IgM (Camargo et 
al., 19/8). The ELISA technique uses antigen absorbed onto microtitre 
plate wells, tc which antibody attaches if present in serum. After 
washing, enzyme-labelled antiglobulin is added and the wells washed 
again. Enzyme substrate is then added and the amount of enzyme hydro­
lysed is measured opeetrophotometrlcaily or visually and reflects the 
amount of antibody presere . Horseradish peroxidase is usually used with 
p-nitrophenyIphosphate or 5-amlnosalicyllc acid as the substrate. This 
technique compares well with the dye test and IFA test, and has the added 
advantage over the dye test of being able to detect IgM.
Radioimmunoassay for toxoplasmosis has also been described, and is 
potentially applicable to detect antibody to purified organism compo­
nents (Gehle et al., 1976).
Another modification of the IFA technique is the FIAX technique, using 
plastic dipsticks on which antigen is absorbed to a cellulose acetate
disc, which is placed in a patient'f, serum, washed, placed in conjugated 
antiserum, washed and the intensity of fluorescence read in a special 
fluorometer. This technique is showing considerable promise by virtue 
of its speed and simplicity, but awaits detailed evaluation (Walls and 
Barnhart, 1978).
Latex particle Toxoplasma agglutination tests have been used, but 
have usually been lacking in sensitivity and difficult to read, 
and have very little place in Toxoplasma serology (Beverley et aZ.,1973).
A microprecipitation method in agar gel has been described by HQbner 
and (Ihlikova (1973), and was found to be positive when the CFT was 
positive. This test does not appear to have any advantages over the CFT
or the IgM-IFA techniques.
From the above, the status of an individual regarding Toxoplasma 
infection can be assessed by performing the dye test or one of its 
equivalents (IFA, IHA), and either the CFT or IgM-IFA. In acute 
infections, dye test seroconversion, rise in titre or single high titre 
(51:4096) in the presence of a positive CFT' or IgM-IFA is found. In 
patients with chronic toxoplasmosis, dye test titres are low and sta’ le, 
and CFT and IgM-IFA tests are negative. In recrudescent infection, ti.j 
dye test titres rise, and CF^ and IgM-IFA tests may become positive 
again. The ELISA and FIAX techniques for toxoplasmosis appear promising, 
and may become the proce lures of choice in the future.
1.9.5 Toxop1asmin skin test 
This measures delayed hypersensitivity and usually appears within 3 
months of infection, and remitL s positive for several decades. It is a 
useful test for screening surveys for the prevalence of chronic toxoplas­
mosis, and may uroful in pati .n .6 wi h retinochoroiditis. Test and 
control materials are injected irrradormally and reactions read after 48 
hours (Frenkel, 1971).
1.10 Treatment
The mainstay of treatment is the use of pyrimethamine and sulphadiazine 
which synerglstically inhibit folate synthesis (Eyles and Coleman, 1953). 
Iosage of pyijunethamine is 75 mg/day for 3 days, then 25 mg/day in 
adultsi I mg/kg/day in infants. Dosage of sulphadiazine is 2 to 3 g/day 
in divided doses in adults, and 100 mg/kg/day in infants (Frenkel, 1971).
Chemotherapy in toxoplasmosis is -ily suppressive until Immunity is 
acquired. Therapy is generally recommended for up to a month. Platelet 
and leukocyte counts should be performed twice weekly to monitor for
folate deficiency, and fclinic acid or yeast should be given to prevent 
thrombocytopaenia and leukopaenia. Dosage of foiinic acid ie 3 to 10 
mg/day orally or intramuscularly, and of yeast is 10 to 20 g/day orally.
Treatment during pregnancy oresents a major problem, as pyrimetha­
mine has been reported to be teratogenic. Spiramycin, a macrolide, has 
been used in pregnancy and appears to be effective in preventing foetal 
transmission if used early enough. It does not cross the placenta or 
affect the severity of disease in the foetus (Desmonts and Couvreur, 1974a).
Trimethoprim-sulphamethoxazole (cotrimoxazole) has been used experi­
mentally, and trimethoprim has been shown to potentiate the action of 
sulphamethoxazole in mice (Sander and Midtvedt, 19 0) and in tissue 
culture (Nguyen and Stadtsbaeder, 1975). Cotrimoxazole has been used in 
man in a few cases of acute infection in adults, with equivocal results 
as therapy is not usually indicated in such cases (Nrrrby et al., 19751.
Clindamycin he been found to be effective in mice with acute 
infection (McMas* r et al., l-4/3) but does not eliminate brain cysts 
during chronic S e c t i o n  in mice as it does not cross the blood-brain 
barrier, although significant clearing of organisms in other organs 
occurs (Araujo and Remington, 1974). No reports of the use of clinda­
mycin in man are available, but this agent appears promising, particularly 
in view of its experimental success in ocular infection (Nozik and O ’Connor, 
1968) and in combination with sulphamethoxypyridazine in acute infection 
in mice (Thiermann et al. , 19 '0).
Tetracyclines have also been investigated for anti-toxoplasmic 
activity, but results have shown that levels required would generally be 
above those obtainable therapeuti illy (Eyles and Coleman, 1954; Perea 
and Daza, 1976). Oxytetracycline has been used with apparent success in 
one human case (Fertig et al., 1977), but further studies are required.
1.11 Epidemiology 
The prevalence cf toxoplasmosis varies from zero in isolated Pacific 
atoll inhabitants (Wallace, 1969) to over 97% in the over 53-year age 
group in Fl Salvador (Remington et <3., 1970). Prevalence of antibodies 
increases with age, and the annual incidence of seroconversion varies 
from zero to 6 percent or more in different parts of the world. Preva­
lence is high in hot, humid climates such as Guatemala, El Salvador,
Easter Island and Tahiti, and low in Navajo Indians and in Eskimos livinc 
in cold, dry climates (Frenkel, 1973b).
The age of maximal seroconversion reflects contact with cats and 
ingestion of raw meat. In El Salvador, the acquisition rate is high 
in children under the age of 5 years, indicating probable oocyst trans­
mission as food is well cooked. In the USA, acquisition is higher in 
adults than in children, indicating probable transmission in meat, which 
also occurs in France, but in all age groups due to eating of raw meat 
by all age groups (Frenkel, 1973b).
The relationship between cats and animal and human infection has 
been studied, and has shown the absence of transmission in the absence 
of cats. In a study by Wallace et al. (1972), where cats lived on 2 of 
3 islets, Toxoptasma antibody was only found on the 2 islets where cats 
were found, and eating habits of the people on the islets suggested 
that oocyst transmission was responsible for human infection. Similar 
conclusions were found in a study by Munday (19/2) in sheep on islands 
between Australia and Tasmania. Island-bred sheep on cat-free islands 
had virtually no seropositive animals, whereas those on cat-infested 
islands had 32 percent seropositive animals.
Antibody studies in animals have shown variable results depending on 
the susceptibility of the species to infection and duration of antibody 
response, which is only a few months in some animals (Frenkel, 1973b). 
Epizootics of toxoplas-moFis causing ovine abortion are well known, and 
transmission is thought to be via oocysts or infected products of 
conception. Prevention of ovine abortion can be achieved by mixing new 
stock with the parent flock soon after the end of the lambing season to 
enable new stock to become infected before they become pregnant in the 
following lambing season (Watson and Beverley, 1971).
From the above studies, cats appear to be important in maintaining 
infection in domestic animals used for meat production, and that tv man 
infections can occur from ingestion of raw or undercooked meat from
such animals.
1.12 Prevention
Human infection occurs via ingestion of cysts or oocysts, and transpla­
cental infection can occur during acute infection contracted during 
pregnancy. The main problem is the prevention of infection during 
pregnancy because of the risk of congenital transmission.
Toxoplaema cysts have been found in pork, mutton, beef, chicken and 
eggs. Pork and mutton are most often involved, but this depends on the 
degree of contact of pigs and sheep with cats.
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Prevention of transmission via meat depends on adequate cooking of 
meat, which should be heated to above 66°C throughout. Freezing reduces 
the number of viable organisms, but does not always kill all organisms. 
Handling of raw meat can also increase the rate of transmission, and 
hands should be washed before touching the eyes or mouth iFrenkel,
1974).
Cats, after primary infection, shed oocysts for about 2 weeks, and 
on reinfection with the same strain, briefly or not at all. Oocysts 
sporulate in 1 to 5 days and remain infectious for at least 12 months. 
Control of the risk of transmission from cats depends on prevention of 
cats becoming infected and on safe disposal of cat faeces. Domestic 
indoor cats are easily controlled by feeding only cooked meat and by 
daily disposal of faeces before speculation can occur. Cat faeces can 
be disposed of by flushing down the toilet, or treating with boiling 
water or dry heat (Frenkel, 1974).
Stray and outdoor cats are a major problem as they acquire infection 
from hunting birds and rodents, and shed oocysts in their faeces, which 
are buried in soil. Oocysts remain viable after speculation in soil for 
at least 12 months, and will survive freezing for more than 4 weeks at 
-21<>c (Ruiz et at., 1973; Frenkel and Dubey, 197?) . Wearing of gloves 
and washing hands after working with soil should decrease the risk of 
infection. Children's sand pits should be covered when not in use, and 
sand replaced if contaminated as effective sterilization cannot be 
achieved (Frenkel, 1974).
Particular attention to these measures should be observed during 
pregnancy. Pregnant women should avoid eating raw or undercooked meat,
and should wash their hands after handling raw meat, cats or soil.
Gloves should be worn for gardening.
The development of a safe va Ine for use in humans and cats is a 
distinct possibility, and work is in progress to determine whether 
different Toxoplasma strains exist f r inclusion in a vaccine (Frenkel, 
1974).
Recommendations for nrevention of toxoplasmosis have been summarized 
by Frenkel (1974) as folio's:
1. Feed cats only dried, canned or cooked meat
2. Keep cats from foraging
3. Change fat's litterboxes daily and disinfect them with boiling 
water
4. If pregnant, wear glovet, if handling litterboxes 01 gardening
5. Cover children's sandboxes when not in use
6. Control stray cats
7. Control flies and coc..-oachn3
8. Avoid eating raw or undercooked meat
C. Wash hands before meals and before touching the face.
1.13 Coccidia related to Foxci.'lasirxi 
The provisional classification of Toxophximi in section 1.3 was proposed 
before the coccidian nature of ToxopUism was known. Following this finding, 
and with recent findings cone rning other poorly classified coccidia, a 
reclassification of the cyst-forming '.us. irid coccidia has been proposed 
by Frenkel (1977). This cl., .sifioa- ion is based on modes cf transmission, 
presence of intermediate host in life cycle, and whether oocysts are shed 
sporulated or unsporulated. Modes of transmission can be homoxenous-faecal 
(oocyst to same definitive host), het eroxenous-faecal (oocyst to intermediate 
host), heteroxenous-carn i v o m u . (cy t to definitive host), or homoxenous- 
carnivorous i-yst to intermediate host).
The isosporid coccidia classified in tais way include the following 
(table 1.4)s
Family EIMERI1DAE
Homoxenous. Tissue cysts are. absent or unknown, and sporulation occurs 
after oocysts are shed. Examplei gen. a in this family arc Iftoepova
(found in birls; oocyst h is t wo igx-.- ocysts, each containing four sporozoites), 
and Eimeria found in bird-, rodent and ruminants) oocyst has four sporo- 
cysts, each containing two spirozoites).
Family SARCOCYSTIDAE 
Keteroxenous isosporid coccidia with cysts occurring in intermediate 
hosts. Sporulation occurs before or after oocysts are shed. Two subfamilies 
are proposed - Sarec:vstina and Td*oplasmatinae. Oocysts have two sporo- 
cysts, each containing fo x ; oz >if.eM.
Subfamily : ARC0CYST1NAE
Cysts only in intermediate hdtit. CystotoJ tes develop directly into 
gametes in gut of dcfin.it iva ho: t. x u illy ihcd an ; omcysts.
Obligatorily heteroxenoue, with t and voio as titflini i.ive host and omnivores 
or herbivores a a int ixtnadiatt hosts.
Genus Sax'cojyBtie
Cysts typically occur in skeletal and cardiac muscle, and arc elongated, 
often with septa. I hi para: t to ha been dcsri .bed in mammal .-t, birds and 
reptiles. The life cycle oi r •'> . a is st.i 1 1 largely unknown. Shedding
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of sporocysts and oocysts has been reported in cats fed Saroooyatie tenella 
from sheep and cattle, and in man, cats, and dogs fed S. fuaiformia from
cattle (Rommel et dl., 1972? Heydorn and Rommel, 1972). These authors sug­
gested that the oocysts of leobpora hominia and I. oc.ti may be those of 
Saroocyatie, but turther confirmation is required. Human infections have 
been described, usually as S. lindematvii infections, but the source of 
infection is not known. Soi'dOdyatte-infected muscle does not transmit 
infection, and little is known about this group of organisms (Frenkel, 1974)
Genus Frenkeiia
Cysts occur in brain and spinal cord of rodents, are thin-walled and 
often septate.
Subfamil) TOXOFLASMATINAF.
Cysts are aseptate, and oocysts are shed unsporulated. A propagative
cycle precedes gametugony in gut of definitive host.
Genus Toxopiaai/k'
Cysts occur in many cell types in both i"" mediate e * definitive 
hosts. Seven species have been included bv l-.v. e (1977) :
T. gondii - type species, ft 1 .dM n finitive hosts.
T. alenoari - r og 
T. bvumpti - ig-;ana 
T. oolubri - snakes 
T. rczuze - t.t g 
T. oerpui - .o- <
T. ^larmondl - cit is definitive host and house mouse xntermediata 
host, classified as Htcrnnondia hcomondi by Frenkel 
(1977) as it is obligatorily hetevoxenous (7. gondii 
i-s facultatively heteroxenous).
Genus Basnoitia
Cysts occur in fibroblasts and possibly other cells, but only in inter­
mediate hosts. Definitiv. host ?, when known, are felids. Described species
are: B. WoXlaooi, B. beonoiti, B. jelliaoni, B. darlingi, ’. tamndi and
fl. bennettl.
Genus Harmondia
Cysts typically occur in skeletal muscle. Obligatorily heteroxenous. 
Species: H. hvmondi (classified as T. namondi by Levine) with rodent-
cat cycle); H. bigemina (?) with cattle-dog cycle.
Genu- Cyroiaoapora 
Monozoic cysts are found in man; tissues, e.g., mesenteric lymph nodes. 
Cysts only infect the definitive host, but oocyst can infect both intermediate
very little information available, 
and complete life cycles are not known.
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and definitive hosts. Known species are C. f e l i d ,  C. ‘i vo l ta ,  C. Vulpina,
C. ohioenaie and C. aania.
In the above proposed classification, generic distinctions are baaed 
on cyst rather than oocyst characteriftics, subfamilial distinctions on 
whether asexual reproduction takes place in the definitive host, and familial 
distinctions on existence or not of tissue cysts. Serologic comparisons have 
shown no significant cross-reactions in the dye test between Beanoitia spp. , 
Saroooyetia muria and Toxoplasma, although the ifa test shows some cross­
reactivity.
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2.0 TOXOPLASMOSIS AND PREGNANCY
Since most Toxoplasma infections in adults are asymptomatic, serocon­
version of the Sabin -Feldman dye test (or alternative test such as 
the IFA test) is the sine qua non in the diagnosis of the infection. 
Passively transferred antibodies in the infant have generally disap­
peared by the age of 6 months, and it is generally agraed that any 
infant with persistent antibodies over this age has congenitally
acquired toxoplasmosis (Hume, 1972).
Many authors believe that congenital infection can only occur during 
primary maternal infection, and that transmission does not occur there­
after. Others feel that congenital transmission can and does occur 
during chronic maternal toxoplasmoat*. A problem complicating assess­
ment of the position is that many congenital infections are asymptomatic 
at birth and are detected by persistent positive serology. However, the 
possibility that asymptomatic seronegative cases at birth can occur has 
been suggested, but no cefinite cases have been described (Hume, 1972).
Tho question of how much of congenital infection is due to acute 
and how much due to chronic maternal infection remains a controversial 
point. Most studies have shown that acute infection during pregnancy 
can result in abortion or congenital infection, there have usually been 
cases in these series with high or rising titres where serologic 
evidence of acute infection is not absolute, and the possibility, however 
remote, of chronic maternal infection could be considered. Since wide 
titre fluctuations may occur in chronic toxoplasmosis, interpretation in 
individual cases can be extremely difficult.
2.1 fnimal studies 
Although the applicability of animal work to man is always suapect, many 
observations have been made. Mice have oftAn been used, but their use 
is problematical as they are immunologically deficient against TOXO- 
plaema.
Chronically infected mice have been shown to transmit congou tai 
infection for at least 5 generations (Beverley, 1959). Spontano .us 
parasltaemia has been demonstrated in mice and rabbits by Remington et 
al. (1961).
The possibility of transmission from uterine cysts has also been 
shown in mice, with congenital infections during chronic infection 
occurring mainly in animals with cyst-containing uteri (Werner and 
Egger, 1969).
The role of immune tolerance has also Jen investigated. In some 
mice, congenitally infected from chronically infected mothers, parasites 
could be isolated despite tnese animals being seronegative. Some of 
these animals also failed to produce antibody on injection with 
formalinized organisms, but parasites could not be recovered from
these animals (Jacobs, 1967).
Strain virulence has also been investigated. The less virulent 
Beverley strain has a greater capacity to produce uterine cysts in mice 
and spontaneous parasitaemia in rats. It is probably that conflicting 
reports in humans could be on the basis of strain and virulence 
differences (Hume, 1972).
2.2 Human studies
Spontaneous parasitaemia has been documented by Prior et at. (1953) and 
Miller et al. (1969). One of these patients had parasitaemia demon­
strable over a 14 month period despite several courses of therapy. Viable 
uterine cysts in humans have also been demonstrated by Remington et al. 
(1960).
2.2.1 Habitual abortion 
Despite categorical denials by most authorities, it is p^ sible that 
occasional cases of congenital infection can occur in c ’ionic toxoplas­
mosis. Much evidence for this form of transmission has come from Langei: 
(1963) who reported isolation of Toxoplasmx from lochia, menstrual blood, 
milk or foetal tissues in 23 of 79 women with habitual abortion. However, 
this work has been the subject of much dispute as to the validity of the 
isolation methods used (Frenkel and Piekarski, 19^8), and Langer nimself 
admitted some doubt concerning possible misidentification of pollen 
grains for Toxoplasma cysts (Langer, 1966). Four of banger's cases were 
reported to be seronegative. Remington et al. (1964) described 3 
patients with chronic infection, 2 of whom aborted and 1 who had a con­
genitally infected infant.
In France, however, studies on 15 000 women with chronic infection 
have not shown a single congenital infection (Desmonts et d ., 1965b), 
and similar results have been reported by other workers (Jacobs, 196/) .
Although by no means settled, it seems probable that, except for 
the very rare occurrence of recurrent transmission in successive 
pregnancies, toxoplasmosis is not a cause of habitual aboition.
2.2.2 Sporadic abortion
It is generally accepted that acute infection during early pregnancy 
will frequently result in spontaneous abortion (Hume, 1972).
2.2.3 Congenital infection
Congenital toxoplasmosis has been extensively studied in France by 
Desmonts and louvreur (1974a, 1974b), and their results have defined 
the extent of the risk of acute infection during pregnancy, the risk 
and severity of congenital transmission, and the complete lack of 
evidence o' transmission during chronic infection.
Their results showed 84% of patients were seroposi' ve, and that 
the seroconversion rate was 6.3 per 100 per year. In the patients 
studied, high antibody titres (>1:1000 dye test titres) or serovoncer- 
sion was detected in 378 cases, who were classified into 2 groups. The 
first groi p (183 cases) had a te infection documented during pregnancy 
(Table 2.1), while the second group (195 cases) had evidence of acute 
infection prior to pregnancy, or where time of infection was unknown 
(Table 2.2).
TABLE 2.1. Data of patien ;s who had acute toxoplasmosis 
during pregnancy (Group ’.)
Find:.nq Number of cases
Seroconversion
Lymphadenopathy with rising titre 21
Lymphadenopathy and high titre ^
Asymptomatic with rising titre 17
TOTAL
TABLE 2.2. Data of patients with acute toxoplasmosis before 
pregnancy or where time of infection could not 
be determined (Group 2)
Number of cases
Acute infectio ‘ before pregnancy
Acute infection around conception
High stable titres
Seroconversion between previous pregnancy 
and first trimester of present pregnancy
TOTAL
Isolation of Toxoplasma was attempted from the placentas of these 
patients, and was positive in 24 of 96 (25*1 in Sroup 1 and in 2 of !G5 
(2*1 in Group 2. The 2 positive Isolates in Group 2 had high stable 
tltres at 6 months' gestation, and were probably acute infections during 
pregnancy. Isolation of organisms free, placentas correlated closely
with the presence of congenital infection.
Of the 376 pregnancies, 11 ended in abortion and 7 were stillborn
or d.«ed soon after birth, excluding the 11 abortions (6 were induced),
the outcome in the remaining cases was as follows - definite congenital
infection in 59 (16%), possible congenita* infection in 15 (4%), and no
congenital transmission in 293 (78%). Sixty-six of the congenital
cases were in Group 1 and 8 in Group 2 (Table 2.3).
TABLE 2.3. Outcome of 369 pregnancies with high antibody 
titres at delivery
No. in Group Congenital infection  ^
Definite Possible
Group 1 
Group 2
176
191
55
4
(31%)
(2%)
11
4
(6%)
(2%)
367 59 (16%) 15 (4%)
* Possiole cases, net proven due to neonatal deaths, 
foetus lost to examination or inadequate fcllow-up
To assess the effect of the stage o* pregnancy when acute infection 
occurred and of treatment of mothers with spiramycin, the remaining 176 
mothers in Group 1 plus the 4 definite congenital cases in Group 2 were
analysed (Table 2.4).
TABLE 2.4. Outcome of 180 pregnancies according to trimester 
----------  material infection was acquired
Trimester Number Congenital infection
Definite Possible
No.
presenting
clinically
1st 30 (17%) 5 (17%) 1
(3%) 5
2nd 84 (47%) 20 (24%) 5
(6%) 13
3rd 39 (22%) 24 (62%) 2
(5%) 2
Undetermined 27 (15%) 10 (37%) 3 (11%)
4
TOTAL 180 (100%) 59 (33%, 11 (6%)
24
The effect of spiramycin treatment Is shown in Table 2.5, and 
severity of disease in Table 2.6. Spiramycin does not affect the 
severity of disease in the foetus as it does not cross the placenta, 
but is effective in preventing spread to the foetus if used early
enough.
TABLE 2.5. Outcome of 180 pregnancies according to 
spiramycin treatment
P ^ t l » g
clinically
Treated
Untreated
98
82
(54%)
(46%)
22
37
(22%)
(45%)
2
9
(2%)
(1 1 %)
12
12
TOTAL 180 (100%) 59 (33%) 11 (6%)_____
24
TABLE 2.6. Severity of disease In 59 definite congenital infections
Severe - s:ill birth, neonatal death, 
serious cerebial damage
Mild - retinochoroiditis 
Asymptomatic
9 (15%)
11 (19%)
39 (66%)
This study by Desmonts tuiCouvreur has shown that congenital 
infections occurred exclusively in mothers with acute infection during 
that pregnancy, however, acute infection only resulted in 33a definite 
and a posslb-> further 6a possible congenital cases, and V a t  severe 
disease only occurred in 15a of the cases, or 6% of maternal infections
during pregnancy.
Transmission occurs less frequently during early pregnancy, but
disease produced is more severe. Spiramycin if used early enough, is 
effective in reducing transmission from 4lit to 24%.
in their studies, Desmonts and Couvreur found that dye test tltres 
in mothers with infected Infants were ,1:1000. and that among over 800 
congenital infection, seen over a 15-year period there were no siblings 
other than twins in their series. They concluded that infection can 
only be transmitted during acute maternal infection and not during 
chronic infection.
In a study by Kimball et al. (1971) in New York, 6 out of 4048 
obstetric patients seroconverted, and 2 of the 6 patients, and a 
further ) of 17 patients with a substantial rise in titre transmitted 
the infection. In England, 9 of 3187 patients seroconverted during 
the second half of pregnancy, but there was no congenital transmission 
(Rouss and Bourne, 1972). In Germany, KraQbig (1966) reported 17 
congenital infections from 3213 patients, and in Brazil, Castilho 
(1976) estimated the incidence of congenital toxoplasmosis in Sao 
Paulo to be 16 per 1000 live births, with 4 symptomatic cases per 1000 
live births.
From the above data, there appear to be marked differences in the 
incidence of congenital infection in different parts of the world, 
being high in Europe, lower in the USA and lowest in England, despite 
an acquisition rate of 0.5 to 1% per year in women of child-bearing 
age. These differences have been ascribed to possible differences in 
virulence, but other factors may be involved (Fleck, 1973).
3.0 TOXOPLASMOSIS IN SOUTHERN AFRICA
Relatively little attention has been paid to toxoplasmosis in Africa, 
but prevalence surveys for seropositivity have be* conducted in 
various parts of Africa, and have yielded prevalence rates of from 9% 
in the San (Bushmen) of South West Africa (Jacobs and Mason, 1978) to 
77% in the Mazda of Tanzania (Bennett et al,, 1970). A tcxoplasmin 
skin test survey in Blacks in Johannesburg conducted by Schr.eide. et 
al. (1955) showed a positive reaction in 31% of 209 subjects. Examples 
of prevalence rates in other parts of Africa are given in Table 3.1 
(Jacobs, 1977). DetaiiS of prevalence studies in Southern Africa will 
b presented in Chapter 5.
TABLE 3.1. Prevalence of Toxoplasma antibodies in Africa
Uganda 12%
Egypt 17%
Southern Africa 20% 
Rhodesia 35%
Kenya 60%
Sudan 61%
Nigeria 65%
Tanzania 77%
3.J Cases of clinical toxoplasmosis in man 
A small1 number of cases of clinical toxoplasmosis has been reported 
in South Africa. The first reported case was by Klenerman (1951) who 
described a 6-week oil Blacx infant with congenital infection. The 
brain contained loxoplaoma cysts and pseudocysts, ana the mother's dye 
test titre was 1:1024. A further 4 congenital cases have been 
described by Rabkin and Javett (1952), asser (1955) and Edge and 
Wallace (1961). Two post-mortem cases in children were reported by 
Becker (1954), but there was very little to substantiate the diagnosis 
in one of these canes. A few cases in adults and children have also 
been reported (Edge and Wallace, 1961; Saunders and Thatcher, 1963;
Te Groen, 1971 and van der Ho st et al., 1972). A summary of these 
cases is given in Tables 3.2 and 3.3.
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The cases of toxoplasmosis reported show that the disease in most 
of its forms occurs in South Africa, the only form not being described 
being recrudescent infection in malignancy. However, many cases of 
infection are probably missed, and to date no successful laboratory 
isolates of r'oxopla8Tna have been made from human material, although 
organisms have been isolated from animals.
3.2 Toxoplasmosis in animals in South Africa 
Dye test antibodies have been found in 12% of 50 dogs ISAIMR, 1957),
100% of 20 cattle, 2 of 3 donkeys, 1 of 5 horses, 00% of 20 pigs, 70% 
of 10 sheep (SAIMR, 1959), and in almost all sheep tested (Bigalke,
1970).
Post-mortem diagnoses of toxoplasmosis have been made in a Cape 
Hunting Dog (Hofmeyr, 1956) aid in 7 dogs seen L'« Pretoria (Smit, KS1) .
The first reported isolation of Toxoplaoma in South Africa was 
from ferrets maintained in a colony at the Onderstepoort Veterinary 
Research Institute, Pretoria. FjfcVS out of 6 ferrets examined were 
found to be infected on mouse inoculation, but the source of infection 
and the reasons for spontaneous illness occurring in the colony could 
not be explained (Bigalke <st a t . ,  1966).
An outbreak of toxoplasmosis in chinchillas in the Western Cape 
was reported by Du Plessis e t  a t . (1967). Over a 3-month period in 
1966, 17% of the 600 animals in the colony died with features including 
letharg., anorexia, diarrhoea and dyspnoea. Organisms and cysts were 
seen in histological material, and isolation of organisms in mice
confirmed the diagnosis.
From the above reports, toxoplasmosis in rodents and meat-producing 
animals occurs in animals in South Africa, and this risk of infection 
via raw or undercooked meat wo.Id be similar to that found in other 
parts of the world. The strains isolated frcm ferrets and chinchillas 
ire the only oblished reports of isolates of Toxoplaoma in South Africa 
from numan or animal sources, but the strains were unfortunately not 
retained for comparison with strains Isolated elsewhere (Bigalke, 19/8).
4.0 METHODS
The methods described were used for the studies described in Chapters 
S to 8, and details of the methods employed are given in this Chapter.
4.1 Serology
4.1.1 Indirect fluorescent antibody (IFAj test 
The IFft test was the standard test used for the studies as the techniques 
involved are simple, equipment and reagents are readily available 
commercially, results are generally accepted as being equivalent to the 
dye test and the prozone phenomenon in the dye test does not occur 
(Fletcher, 1965). The only disadvantage of the IFA test is the possi­
bility of false positive reactions caused by sera containing anti-nuclear 
antibodies (Araujo et al., 1971) , and the necessity to have the required 
anti-species conjugate.
The IFA test was employed for huaan, sheep and mouse sera using 
fluorescein isochiocyanate labelled anti-human conjugate, anti-human IgM 
conjugate, anti-sheep conjugate and anti-rat conjugate (all obtained 
from Wellcome Reagents, Br-kenham, England). All conjugates, except for 
the anti-human IgM conjugate, were titrated out with control sera to 
obtain the titre for use ir. the test. Control positive and negative 
human and sheep sera were obtained commercially (Wellcome Reagents? 
Behriniwerke, Marburg, West Germany? and Roche Diagnostics, Basel, 
Switzerland). Negative mouse serum was obtained from normai mice, 
and positive mouse serum from mice injected with the antigen used in 
the IFA test? these sera were tested with the dye test to confirm the 
negative serum and obtain the titre of the positive serum. Typical data 
on conjugate titrations are shjwn in Table 4.1.
Control human serum for anti-ToxopZaama IgM antibody determination by 
the IFA technique was not available commercially and could not be obtained, 
and the anti-human IgM conjugate was standardized as fellows. Sera from a 
patient with * ute toxoplasmosis were obtained at intervals over a 14- 
month period after presentation, and were tested with different dilutions 
of anti-IgM conjugate, with results as shown in Table 4.2. As IgM titres 
generally are low or become negative after a year, the conjugate dilution 
iu which this occurred with the patient's sera was assumed to be at a
suitable dilution for testing other sera for anti - Toxoplaemz IgM anti­
bodies. For the conjugate used, which was from the same batch through­
out, a 1:20 dilution fulfilled these requirements. In view of the 
problems reported with some anti-IgM conjugates tRemington and Desmonts, 
1973), the IgM-lFA test was only performed on selected sera, and titres 
of *1:16 were regarded as significant.
TABT-f 4.1. Data on fluorescein-labelled conjugates used in 
the IFA test. All conjugate t were ootained from 
Wellcome Reagents
Anti-human 
immunoglobulin
Anti­
human
IgM
Anti-sheep 
immunoglobulin
Anti-rat
immuno­
globulin
Species produced in 
Lot Number
Fluorescein/protein
ratio:
optical aensity 
molar
Protein (mg/ml)
Antibody protein (mg/ml)
Gel diffusion reacti­
vity against human:
IgG
IgM
I I
Signif i J..nt cress - 
reaction with anima’ 
sera:
Sheep
K8872 4 
K9070
0.646
2.8
9.85
3.1
+
+
+
Sheep
K2934
0.72
3.2
7.2 
Not stated
Rabbit
K2537
0.92
4.5
8.2
1.2
Rabbit
K1378
).76
3.5
6.3
1.7
Monk-iy
Cow
Goat
Sheep
Mouse
Rat
Rabbit
++
++ 
++ 
+ f+
++
+++
Working dilution 1:80-
1:120
1:20 1:40 1:10
TABLE 4.2. Standardization of anti-human IgM conjugate
with sera from a patient with acute toxoplasmosis
Time after IFA Titre with anti-human IgM conjugate used
presentation titre In dilutions of
(months) 1:10 1:20 1:40 1:80
2 1:16384 1:512 1:512 1:256 1:128
14 1:8192 1:16 1:8* 1:8* 1:8*
* IgM-IFA test regarded as positive at titres >1:16 only
The antigen used was killed lyophilized whole organisms obtained 
commercially from Wellcome Reagents and later from Roche Diagnostics.
The reason for the change was the finding of several vials of antigen 
containing very few parasites, while the number of organisms from the new 
source was found to be as stated. The antigen was reconstituted from the 
lyophilized state according to the manufacturers' instructions, and the 
number of organisms was counted in a Fuchs-Rosenthal counting chamber.
The antigen was, if necessary, diluted with phosphate buffered saline to 
contain approximately 2.5 x 10^ organisms per ml, and was not used if 
there were fewer than this number in the reconstituted vial. This number 
of organisms was found to give 40 to 60 single organisms per high power 
field. In the antigen obtained from Wellcome Reagents, organisms tended 
to clump together, and this clumping was removed by squirting the antigen 
tlirough a 26-gauge needle a few times, and this was routinely done on 
all vials of antigen. The correctly diluted antigen was applied onto 2.5 
mm spots on multi-spot slides with a 1 ml syringe with a 26-gauge needle. 
Slides were allowed to air-dry and were kept in air-tight containers at 
-20-C until used. The contents of the whole vicl were applied to slides 
after reconstitution. Multi-spot lides were initially made by hand 
using glycerine drops sprayed with teflon aerosol spray, and later 
obtained commercially from Dynatech Laboratories (Surrey, England) with 
the same specifications. Multi-spot slides contained 26 spots, each 2.F 
mm in diameter, as shown in Figs. 4.1 to 4.3. Eight sera could be 
screened in 3 dilutions or 3 sera titrated for 8 dilutions per slide, 
while the 2 extra spots could be used for positive and negative controls 
on each slide to check microscope function. No differences in performance 
were found between the antigens from the 2 different sources.
Phosphate-buffered saline (PBS) pH 7.2 was used as the diluent for
all IFA test procedures such as antigen, serum and conjugate dilution, 
and all washing stages. PBS in powder form was obtained commercially 
(Difco Laboratories, Detroit, USA) in vials containing 7.65 g NaCl,
1.2688 " disodium phosphate, 0.1 g monosodium phosphate and 0.2113 g 
monopotassium phosphate per vial. Eacn vial was made up to 1 litre in 
a volumetric flask with reagent-grade water (reverse osmosis water 
processed through deionizing resins), and the pH measured and if necessary 
adjusted. Particular attention was paid to checking the pH on each litre 
of PBS made uv W  PBS wan only used on the day it was made up, ana
left-over sol .. was discarded at the end of the day.
After conjugates had been titrated out with control sera, the IFA
test was performer. follows:
1. Suitable doubling dilutions of test sera (inactivated at 56°C for
30 minutes) were made in microtitre plates using microtitre droppers
and diluters (Dynatech).
2. Sufficient serum of each dilution was placed onto each spot with a 
Pasteur pipette. The same pipette was used for the same serum, 
starting with the highest dilution. Sera were routinely screened at 
dilutions of 1:8, 1:16 and 1:32, and titrated out further if positive
at 1:32.
3. Positive and negative control sera were placed on a slide as shown 
in Fig. 4.2, and the 2 left-hand spots on further slides used for 
positive and negative controls on each slide as shown in Fig. 4.3.
4. Slides were incubated at room temperature for 30 mins in a humid
chamber and serum spots then rapidly flushed off with PBS.
5. Slides were placed in a staining rack and washed in PBS on a magnetic
stirrer at slow speed for 30 mins, with a change of PBS after 15
mins, and then blotted dry.
6. A drop of conjugate in working dilution (conjugate working dilution
made up fresh each day) was placed on each spot with a Pasteur 
pipette and slides incubated at room temperature for 30 mins in a 
humid chamber. Conjugate was diluted with PBS containing Evans' Blue
in 1:10 000 dilution.
7. Conjugate was flushed off slides with PBS, and slides washed and
dried as in 5.
8. Slides were mounted in buffered glycerol (9 parts glycerol to 1 part 
PBS), covered with a cover-slip, and examin'd under 600 X magnifi­
cation on a fluorescent microscope.
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Fig. 4.1. Layout of multispot slides used for the IFA test. Eight 
sera could be screened in 3 dilutions, using spots vertically, or 3 
sera titrated for 8 dilutions using spc’-s horizontally, using the 2 
left-hand spots for positive and negative controls.
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Fig. 4.2. Layout of control slide used in duplicate for each hatch of 
IFA tests. In this example, titre of positive control serum is 1:64 
and serum dilutions were placed on the slide bo that the change from 
positive to negative should occur between the 4th and 5th spots. Control 
slides were satisfactory if the 2 left-hand spots and the centre row- 
showed no fluorescence, the positive control showed 1+ to t fluorescence 
within 1 doubling dilution of the expected titre and the negative control 
no more than t fluorescence at a 1:8 dilution.
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Fig. 4.1. Layout of multisyot slides used for the IFA test. Eic;ht 
sera could be screened in 3 dilutions, using spots vertically, ur 3 
sera titrated for 8 dilutions using spots horizontally, using the 2 
left-hand spots for positive and negative controls.
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Fig. 4.2. Layout of control slide used in duplicate for each batch of 
IFA tests. In this example, titre of positive control serum is 1:64 
and serum dilutions were placed on the slide so that the change from 
positive to negative should occur between the 4th and 5th spots. Control 
slides were satisfactory if the 2 left-hand spots and the centre row 
showed no fluorescence, the positive control showed 1+ to t fluorescence 
within 1 doubling dilution of the expected titre and the negative control 
no more than t fluorescence at a 1:8 dilution.
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Flq. 4.3. Layout of test slides used for screening 8 unknown sera 
in 3 dilutions (upper figure) or titration of 3 screened sera for 
8 dilutions (lower figure). Sera still positive at 1:2048 were 
titrated out to their end-point. Positive and negative control 
sera on the 2 left-nand spots enabled checking of microscope function 
for each slide.
After the reconstitution of a vial of lyophilized conjugate, the 
conjugate was kept at 4°C if expected to be used within a few weeks, 
or frozen in aliquots at -20°C if infrequently used. All conjugates 
used performed satisfactorily and were used in dilutions of 1:10 to 
1:120. Conjugates were checked for anti-Toccoplaema activity, which was 
absent, but the anti-human IgM conjugate tended to cause polar staining 
with many sera. Conjugates wore diluted in Evans' Blur :,n 1:10 000 
dilution to reduce non-specific fluorescence and to enab.'.e the presence 
of unstained organisms to be seen. Evan's Blue was kept as a 1:1 000 
stock solution in distilled water at 4°C.
Slides were read with a Reichert transmitted light microscope, with 
a halogen light source, fillers for fluorescein fluorescence, dark field 
condenser and glycerol immersion objectives. During the later part of 
this study, a Leitz Ortholux incident light microscope was used. This 
microscope had a halogen light source, filter modules for fluorescein 
fluorescence and oil immersion objectives. The Leitz microscope gave 
more powerful fluorescence ind required re-titraticn of conjugates to 
obtain equivalent results to that obtained with the same controls on the 
Reichert microscope.
The IFA test was read as positive if organisms showed a complete 
ring of fluorescence, and intensity of fluorescence was graded from 4+ 
to ±. Readings of 1 fluorescence were regarded as the end-point. Polar 
fluorescence, which was particularly noticeable with the anti-human IgM 
conjugate, was disregarded.
Random sera tested Ly the IFA method were sent for checking with the 
dye test by the Tropical Diseases Department of the South African Institute 
for Medical Research, ■ all dy test results were within 1 doubling 
dilution Sf the IFA r« ult . Sera checked with the dye it-p . included high 
and low titro positive a «i 11 a negative sera.
4.1.2 Complement fixation Test (CFT)
This test was carried out micro*itre plat - s according to the method 
described in Public Health M ic ,•ap No. } (t S Public Health Service, 
1965), using microti tr t i methods md a SO percent haemolysis (CH^ > 
end-point for complement t it rat ion. The method used the followin' ratios 
of reagents - 1 volume :h ol patient's scrum, antigen and sensitised 
red cells, and 2 volume r a complement, as follows:
Buffer
Veronal buffered saline (VBS) pH 7.2 uo 7.4, containing 8.3 g NaCl,
1.02 g sodium barbital, 0.1 g MgC^'Bl^O, 0.022 g CaCl ,"2H,0 and 3.46 
ml 1 N HCl per litre, was made up from commercial tablets (Oxoid Ltd., 
Basingstoke, England) with the addition of 0.1% gelatin (Difco Labora­
tories) . VBS was made up on the day before use, autoclaved for 
sterility, kept at 4°C and always used cold.
I^activation of test sera
Sera were inac.ivated for 30 mins at 56cC prior to testing. If sera 
were to be stored, chey were inactivated before freezing and re- 
inactivated when thawed prior to testing.
Sheep red blood cells
Sheep blood was collected aseptics!ly in an equal volume of A1sever1a 
anticoagulant solution (containing 20.5 g dextrose, 4.2 g NaCl, 8.0 g 
sodium citrate, and 0.55 g citric acid per litre). Alsever's solution 
was sterilized by filtration through a 0.22 um Millipore membrane. For 
use, red cells were spun down and washed twice in VBS, and then sus­
pended to approximately their original volume in VBS. Samples of this 
suspension were placed in 2 capillary tubes and spun in a microhaemato- 
crit centrifuge to obtain the haematocrit. The ce1! suspension was then 
diluted to give a 2.8% red cell suspension, using the formula:
haematocrit % ... „ „ .. , g  * dilution factor of cell suspension.
Haemolysin titration
This was performed for each bottle of sheep haemolysin used, as follows:
1. Haemolysin (Wellcome Reagents) was diluted in doubling dilutions
from 1:100 to 1:6400 and from 1:150 to 1:4800 in 0.2 ml volumes.
2. 0.2 ml of 2.8% sheep red cells was added to each tube.
3. 0.8 ml complement at lCH^n was added to each tube (see complement
titration).
4. 0.8 ml VBS was added to each tube.
5. Tubes were incubated for 30 mins at. 37°c, being shaken after 15 
mins and then centrifuged.
6. Percentage haemolysis was read on a Unicam spectrophotometer at a 
wave-length of 540 pm, using VBS as the zero point and 0.2 ml of 
2.8% red cells with 1.8 ml distilled water as 100% haemolysis.
7. Percentage haemolysis was plotted against haemolysin dilution, and 
haemolysin dilution read on plateau cf graph as shown in Fig. 4.4. 
For the actual test, 2 haemolysin units were used.
HAEMOLTSIN CMLUDON
Fig. 4.4. Haemolysis titration. A 1:800 dilution is 1 haemolysin 
unit, and a 1:400 dilution (2 haemolysin units) final 
dilution should be used for the CFT.
Haemolysin titration was only necessary for each bottle of 
haemolysin opened, and does not need to be performed each time a 
CFT is done.
Sensitisation of Sheep Red Cells
Standardised 2.8% sheep red cells were added to an equal volume 
of haemolysin diluted in VBS to give a final concentration of 2 
haemolysin units with 1.4% red cells. Red cells and haemolysin 
wore mixed slowly and thoroughly, and allowed to stand at room 
temperature for 10 minutes to sensitise. Sensitised cells can 
be kept at 4 C for use the next day.
Complement Titration 
If haemolysln titration has not been performed, excess haemolysln (ey 
1:100 dilution) should be used until naemolysln titrat 13.1 is performed. 
Complement titration must be performed each time a CFT is performed.
Complement used was fresh guinea pig serum used on day of collection 
or within 3 weeks kept at -20°C in aliquots and thawed immediately 
prior to use. All manipulations of complement were carried out as 
quickly as possible on ice.
The method used was performed in tubes as follows:
1. Sensitised red cells were prepared as above.
2. Complement was diluted 1:5 and kept at 4°C.
3. CompIfroent was diluted from 1:5 to 1:100, and a further series of 
dilutions in duplicate in 0.4 ml volumes made from the 1:100 
dilution. These dilutions made we_e 3 doubling dilutions each 
from dilutions of 1:200, 1:250, 1:300 and 1:350, giving dilutions 
of 1:200 to 1:1400.
4. To each complement dilution, 0.4 ml VBS and 0.2 ml sensitised cells 
were added.
5. All tubes were mixed and then incubated for 30 mins at 37 C, shaking 
after 15 mins, centrifuged, ana percentage haemolysis read as 
described under haemolysln titration.
6. The average percentage haemolysis from each pair of tubes was 
calculated, and the percentage haemolysis (Y-value) determined to 
the nearest 5% for 2 values above and 2 below 50% haemolysis. Y- 
values were converted to Y/100-Y values according to the conversion 
table (Table 4.3).
7. Complement dilutions were plotted against converted Y-values on 3- 
cycle log/log paper as shown in example in Fig. 4.5. The C H ^  at 
the converted Y-value of 1 (50% haemolysis, was read from the line 
plotted and the slope of the line determined. The slope of the 
line should ideally be 0.18 to 0.22 for reproducibility, and fresh 
complement should have a CH^^ of 1:400 to 1:600. For the CFT,
SCH.y units were used.
TABLE 4.3. Converted Y-values of percentage haemolysis
(converted Y-value is % lysed /% non-lysed cellsl
Percentage
haemolysis
Converted
Y-value
Percentage
haemolysis
Converted
Y-value
(Y-value) (Y/100-Y) (Y-value) (Y/100-Y)
10 o.iu 55 1.22
15 0.176 60 1.50
20 0.25 65 1.86
25 0.33 70 2.33
30 0.43 75 3.0
35 0.54 80 4.0
40 0.67 85 5.7
45 0.82 90 9.0
50 1.0
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Fig. 4.5. Complement Litration. Tlie CH^q is 1:440, and SCH^q (1:88) 
should be used.
Antigen Titration
Block antigen titration must be performed on all batches of antigen 
used, and typical results are shown in Fig. 4.6. Antigen titration 
was performed in microtitre plates as follows:
1. 0.02b ml positive control serum was added to wells 1 to 8 in row
F , and negative control serum to wells 9 and 10 in row F with 0.07b
ml VBS.
2. Sera were diluted with VbS in rows A to E, obtaining dilutions from
1:8 to 1:128 in 0.025 mi volumes.
3. 0.025 ml an-ijen was added to rows A  to E  and F and G as follows -
antigen in 1:2 dilution to row 1, 1.4 to row 2, 1:8 to rows 3 and
0, 1:1V to row 4, 1:32 to row 5 and 1:64 to row 6. Control antigen
in 1:8 dilution was added to row 7.
4. 0.05 ml of 5CH50 complement was added to all wells in row A ana to 
rows 1 to 10 from B to E and G 0.05 ml 2.5CH5o was addec to wells
1 to 10 in row H and to B 11 an, 12, 1.25CH50 to Cll and 12, and 0.6
Cigo to Dll and 12.
5. Volumes in all wells were mad, up to 0.1 *1 with VBS where necessary.
6. Plates were covered, mixed gently and i. cube ted overnight a> 4%.
7. Plates were removed from tb< refrigerator on the next day and allowed
to reach room temperature.
8. 0.025 ml sensitised red cells were added to all wells (including Hi2
with 0.1 ml VBS).
9. Plates were reeled, mixed we.. 1 and incubated at 37°C for JO mins,
shaking after 15 mins. 
lU, f u i e  were left to settle for 2 hours, or centrifuged and read.
Plates were interpreted as follows:
4+ - no haemolysis
3v, - 25% hramolysis
2+ - 50% haemolysis
1+ - 75% haemolysis
+ - 90% haemolysis
0 - 100% haemolysis
3iroj|dnp uj <xi 
s\oj;u o 3 
UieujeidiuoQ r
uefii^io o
uoitniip 91 u|
ueCuuv > \
ueO}4UD on to
upimiip e i4 
U*6*4UO IOJ4UOO h-
$ CO
%  -
CM
3©
© © © © © r o © ©
.“ ) ©  
I S ©
D3© @©®®©©©0©©
CM
1^1
jo  NOu.mia ni
W083S "lOtilNOO 3AlHSOcJ
CM
53.
(0
u k 
(0 <D
in
! !
9NINIV1NOO
JN3W31dHNOO
4-1 C « to
e ^ i h-H id to
4J V  4t• 41 t. 4J 
C VO 43 « fl 
4) *4 U
tji Q ' -H
•*■1 4J U) *0
*4 0 C Cq —< 0) ft
3 >. O'
O -H to(0 *4 0)
Z C  k
tr to id
W TJ 0' T)
(0 J3 i
O ♦> t)
M  *4 4) to 43 >w 43 
< +4 O W
</> u.
-J O
!i
V)
Test antigen ru*>
-A—
1 = 5
of "510 f2oo o
164 5
6 7 e
NEGATIVE 
CONTROL 3ERUM 
IN ROWS A TO E 
WITH
|
1
. -o
eCO
<U
l l 1
o  o .£
II 12
1=8 A
i i  j
1=32 C
>64 D
5 CH50
2 5 CH50
25 CH
0 6  CH
50
50
SERUM 
DILUTION F 
ROW
5 C H ^ G
2 5 C H ^ H
RED CELL 
CONTROL
u
in the example shown in Fig. 1.6, interpretation is as follows:
1. Red cell control (12 Hj shows no haemolysis.
2. Complement controls (11 and 12 A to D) - amount of complement 
used was adequate and complement has not deteriorated.
3. Complement and antigen controls (G and H 1 to 7 and 9) - antinen 
and control antigen show no significant anti-complementary 
activity.
4. Serum anti-complementary controls (8 and 10 A to E) - control sera
not anti-complementary.
5. False positive control (7 A to E) - positive control does not give 
false positive reaction with control antigen.
6. Negative control serum gives negative result with antigen in 1:8
dilution (9 A to E).
7. Positive control serum gives titre of 1:32 at antigen dilutions of 
1:8 and 1:16, 1:16 at 1:4 antigen dilution and 1:8 at 1:2 and 1:32 
antigen dilutions. As the expected titre is 1:32, system is working 
correctly and antigen should be used at 1:8 dilution.
Complement Fixation Test Performance
In microtitre plates, the CFT was performed using 0.025 ml volumes each 
of diluted serum, antigen and red cells, and 0.05 ml volumes of comple­
ment. Plates were set up as shown in Fig. 4.7. as follows:
1. 0.025 1 inactivated serum and 0.075 ml VBS were added to wells in
row F 1:4 dilution). Positive and negative control sera were 
includi .
2. 0.025 ml VBS was added to wells in rows A to E, and G and H.
3. Using microtitre diluters, sera were diluted from row F to rows G 
and H, producing 1:8 and 1:16 dilutions respectively.
4. Diluters were blotted and sera diluted from row F again into rows 
A to E, producing dilutions of 1:0 to 1:128.
5. 0.025 ml antigen in optimal dilution was added to wells in rows
A to E.
6. 0.025 ml VBS was added to row G.
7. 0.025 ml control antigen in same dilution as test antigen was added 
to row H.
8. 0.05 ml complement containing SCH^q• made up from the 1:5 complement 
dilution was added to all wells in rows A to E and G and H.
Complement controls - 2.5CHgQ, 1.25CHc,q and Q.6CH<jq complement 
dilutions were prepared. In row A 0.05 ml BCH^q was added to 3 
wells (eg rows 10 to 12) and similarly in rows B, C and D 2.5, 1.25 
and 0.6CHc,0 respectively were added. 0.05 ml VBS was added to the 
wells used in row 10, and 0.025 ml VBS to rows 11 and 12. 0.025 ml
antigen was added to row 11 and 0.025 ml control antigen to row 12. 
Plates were covered, mixed gently and incubated overnight at 4°C. 
Plates were removed from the refrigerator on the next day and 
allowed to reach room temperature.
0.025 ml sensitised red cells were added to each well and to a 
control well with 0.1 ml VBS (eg row 12 H).
Plates were sealed, mixed well and incubated at 37°C for 30 mins, 
shaking after 15 mine.
Cells were left to settle for 2 hours, or centrifuged, and read.
CFT microtitre plates were read as follows:
4> - no haemolysis
3+ - 25% haemolysis
2+ - 50% haemolysis
1+ - 75% haemolysis
± - 90% haemolysis
0 - complete haemolysis
Interpretation of CFT:
Red cell control (12 H) should read 4+ (no haemolysis).
Complement controls (row 10)
Row A (SCHgg) should read 0 (complete haemolysis)
Row B (2.5CHfj0) should read 0 to t 
Row C (1.25CHqg) should read *’ to 2+
Row D (O.6CH50) should read 3t to 4+
Antigen and complement controls in rows 11 and 12 should read the 
same as row 10 if antigen find control antigen are satisfactory 
ana are not anti-complementary.
Serum anti-complementary controls - all wells in row G should read
0. Any sera showing 1+ to 4+ are anti-complementary.
Serum false positive controls - all wells in row H should read 0. 
Any sera showing 1+ to 4+ are giving false positive results. 
Positive control serum should give 3+ to 4+ reading within 1 
dilution of correct titre, and negative control serum should be 
0 throughout.
5 6 .
7. Unknown sera can then be read as positive at the highest dilution 
fbowing a 3+ to 4+ reading.
8. Anti-complementary sera can be treated with an equal volume of 1:5 
complement at 37°C for 30 mine and inactivated again at 56°C for 
30 mins, and then reterjted.
Interpretation of the example shown in fig. 4.7:
Red cell control is correct.
Complement controls are correct (10 A to D) and antigens are not anti- 
complementary (11 and 12 A to D).
Anticomplementary controls - serum in row 5 is anti-complementary.
False positive controls - serum in row 8 is giving a false positive 
result.
Control sera are correct (expected titre of positive serum is 1:32).
Serum in row 3 is positive, titre 1:16.
Sera in rows 4, 6, 7 and 9 are negative.
Many problems were encountered in the performance of the CFT, 
Reagents other than antigens and control sera were readily available, 
but antigens and control sera tould only be obtained from Behringwerke, 
the only other manufacturer being Xtaldiagnostics which was not repre­
sented in South Africa. Initially, when the CFT was set up the positive 
control serum was found to be highly anticomplementary. This problem was 
overcome by treating the control serum with complement as described in 
8 above, and the test then performed well and gave clear results. At 
that stage antigen batch A31B, expiry July 1975, was being used, and was 
Btill giving good results up to early in 1976. At that stage batch
3539c, expiry May 1977, was obtained and tested in parallel with the old
batch. The new antigen was found to be sigr. ificantly anticomplementary.
Early in the study, the husband of one of the patients who sere­
converted in the pregnancy study was also found to be CFT positive at a
titre of 1:16, and from then on his serum, which was frozen in small 
aliquots, was used as a positive control, and remained satisfactory for 
3 years before becoming anticomplemer*-»ry.
The manufacturers of the unsatisfactory antigen and control serum, 
Behringwerke, were informed of these problems and this led to my visiting 
tiieir manufacturing plant in Marburg. Behringwerke agreed that the 
products were anticomplementary in the microtitre CFT, but stated that
57.
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this did not occur when they used their antigen in the macro method.
They could not explain the differences between antigen batches on their 
manufacturing procedures, and could not explain either why the macro 
and micro methods should give different results. They did not find the 
positive control serum to be anticomplemrntary j.n their laboratories, 
and they considered this to be caused by problems in transport to South 
Africa.
Fortunately, the manufacturers had a supply of the A32B batch of 
antigen, and this was used and remained satisfactory despite being used 
for 3 years past expiry date.
4.1.3 Haeraagglutlnatlon Test 
The indirect haemagglutination (IHA) test was performed using the 'Tox 
HA test' haemagglutination kit (Wellcome Reagents). The test uses 
sonicated soluble extracts from endozoites to sensitise formalin-treated 
tanned turkey red blood cells. The turkey red cells were provided lyo- 
philized, and unsensitised cells were provided as controls for non­
specific haemagglutination. Positive and negative control sera and 
buffer were also provided. After reconstitution, the red cells must be 
used within 8 hours, or they can be frozen at -20°C for up to a month and 
thawed before use. Sera to be tested should be inactivated at 56°C for 
30 mins.
The Lest was performed in V-bottom microtitre plates as follows:
1. Four-fold dilutions of test and control sera were prepared in wells 
of V-bottom plates in 0.1 ml volumes. Two wells containing serum 
dilutions of 1:16, and 1 well contair g serum dilutions of I 64, 
1:256, 1:1024 and 1:4096 were prepared.
2. 0.025 ml test cells were added to all wells from 1:16 to 1:4096 and
to a blank well.
3. 0.025 ml control cells were added to the second 1:16 serum dilution 
row and to a blank well.
4. Plates were tapped to suspend cells evenly and left covered for at 
least an hour.
5. Positive results showed an agglutination pattern forming a carpet or
thin ring of cells. Negative results showed a button of cells in
the centre of the well. Control cells should show no agglutination, 
and if agglutination occurs, the test cannot be read.
6. Positive and negative sera should give correct results and cell
controls should show clear buttons.
The haemagglutination test was used to test sheep and mouse sera 
as problems with the IFA technique were expected. The test did not, 
however, perform well and difficulty was experienced in reading end­
points, which tended to fade out indistinctly rather than giving a clear- 
cut end titre. This was particularly noticeable for sheep sera, and the 
kit does not appear to be very suitable for testing sera from these 
-nimals. In view of the high cost of the IHA kits, human sera were not 
tested by this method.
4.2 Total IqM Determination
IgM levels were determined by radial immunodiffusion according to the 
method described by Shulman (1973). Wells, 2 nun in diameter, were cut in 
9 cm disposable petri dishes, and 52 wells could be cut per plate. Plates 
contained 8 m1 of 1% purified agar (Behringwerke) made up in barbitone 
buffer (1.38 g barbitone and 4.3 g sodium barbitone per litre) and con­
taining a 0.1 ml of anti-IgM serum (Dako Immunochemicals, Copenhagen, 
Denmark). 0.1 ml was found to be the optimal volume of anti-IgM serum 
for use when different volumes were tested against control sera. Wells 
were filled with 5 ug of serum and plates read after 24 hours at room 
temperature.
Ring diameters of unknown and control sera (6 dilutions of a 
reference serum applied twice per plate) were read on a viewing box. 
Calllbration curves of the standards on aach plate were drawn up xi 3 
cycle semilogarithmic paper, and values of test sera read off (Fig. 4.8).
4.3 Isolation in Mice
Isolation of Toxoplnwha in mice was attempted on specimens of human 
placenta and sheep diaphragm.
Specimens were refrigerated in saline containing penicillin G (25 
units/ml) and streptomycin (25 pg/ml) for a maximum of 3 days before 
being processed.
For placental specimens, a small piece of placenta was ground in a 
iffith’s tube in a small volume of saline, and 1 ml injected intra- 
>eritoneally into 4 mice.
For sheep diaphragms, about 50 g was cut up finely with scissors 
and digested with 500 ml of artificial gastric juice containing 1.3 g of 
pepsin powder 1:10 000, 2.5 g NaCl and 3.5 ml concentrated HC1 (Work, 1971).
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Fig. 4.8. Cord blood total IgM level calibration curve.
Digestion was allowed for 2 hours at 37°C in z> shaking apparatus in 
,i water bath, and the suspension was then filtered through a double 
layer of gauze and centrifuged for 15 mina at 2 000 rpm. The super­
natant was poured off and the sediment resuspended in PBS, recentri­
fuged , and finally suspended in 5 ml of PBS. Four mice were each 
inoculated intraper1tonea1ly with 1 ml of the suspension.
Two mice from each group were bled and killed after a week and 
peritoneal smears stained with Giemsa stain for organisms. Hie other 
2 mice were bled and killed Lfter 6 to 8 weeks, and crush and smear 
brain preparations were examined for cysts, and brain, liver and spleen 
passaged into a further 2 mice per organ. Passaged animals were examined 
after 6 to 8 weeks and discarded if negative after the third passage.
IFA tests were performed on all mouse sera as described in 4.1.1.
4.4. Lymph Node Examination 
Lymph node sections were examined by routine haematoxylin and eosm 
staining and by direct immunofluorescence.
As lymph nodes had been formalin fixed, they were processed according 
to the method of Huang ct czZ. (1976) as follows. Four wm sections were 
cut from paraffin blocks and placed on slides (the method described by 
Huang et nl. used a resin to bind the section to the slide, but this was 
omitted as the resin was unobtainable). Sections were dried, depara- 
finized and rehydrated, ar.l digested in trypsin solution for 2 hours 
(trypsin solution made up of 0.1% trypsin powder, 0.1% CaClg in distilled 
water, pH adjusted to 7.8 with 0.1 N NaOH). After digestion, sections 
were washed in distilled water and then immersed in PBS for 30 mins.
Digested tissues were then encircled with teflon and direct anti™ 
Toxoplasma conjugate (Wellcome Reagents) in 1:50 dilution was placed on 
the sections for 60 rains at 37°C in a humid chamber. Direct conjugate 
was obtained from Wellcome Reagents. A portion of this conjugate was 
absorbed out with organisms used in the IFA test to remove anti-Toxoplasma 
antibodies. 0.5 ml of the conjugate required absorption with 30 million 
organisms before absorption was complete. The absorbed conjugate was used 
in parallel with the conjugate, and direct fluorescence was only regarded 
as positive when fluorescence occurred with the conjugate and not with 
the absorbed conjugate. Conjugate and absorbed conjugate were controlled 
by application to antigen slides used for the IFA test, and fluorescence 
occurred with the conjugate up to 1:8000 dilution, but not in the absorbed 
conjugate at 1:10 dilution. Omission of the use of the resin in the method 
followed did not appear to affect the performance of the method, and the 
tissue sections remained on the slides.
5.0 PREVALENCE OF TOXOPLASMA ANTIBODIES IN SOUTHERN AFRxCA
As the prevalence of Toxoplasma ar.tibodies In Southern Africa had not 
been studied, information on seropositivity rates and on the interpre­
tation of serology on individual patients was therefore not available.
T.ie on.’y published study was n skin test survey in Blacks in the 
Transvaal conducted by Schneider al * (19551 , in which 311 of persons 
tested were found to be toxoplasmjn positive.
In view of this almost complete lack of information on toxoplasmosis
in Southern Africa, I undertook serological surveys for toxoplasmosis
in 5 major areas of Southern Africa. These surveys were carried out
in the Parasitology Department in collaboration with Pr PR Mason.
The IFA technique was chosen for these surveys in view of its simplicity, 
whilst giving results similar to those obtained in the dye test (Fletcher, 
1965).
These surveys, on populations representative of the different areas 
and ethnic groups ir Southern Africa, were conducted during the period 
1973 to 1977, and the results are shown in this Chapter. The studies under 
taken surveyed 806 persons in the Transvaal in 1973, 3379 persons in the 
Cape, Natal and South West Africa during 1974 to 1976. and 6705 pr.tlents 
tested at delivery in the Transvaal during 1975 to 1978. The only 
Province in South Africa not surveyed was the Orange Free State as this 
was done by Brink et al. (1975) in 1974, and these results are used for 
comparative purposes.
5.1 Patients and Methods
Sera were obtained from healthy .arsons 1,. the community during employment 
:n' antenatal screening, from blood donors at blood transfusion centres, 
fr-m research surveys to South West Africa and Botswana, from cat show 
exhibitors and from medical students. Sera were stored at -20°C until 
tested, and were tested by the IFA method as described in Chapter 4. 
Differences in prevalence were compared using the x7 test of -tgnificance.
5.2 Results
5.2.1 Transvaal
In the original survey of 806 sera, 37% (296) were positive in the IFA 
test at a dilution of *1:16. The results were analysed according to 
ethnic group, age and sex, and are shown in Tables 5.1 to 5.4.
table 5.1. Toxoptoma TFA titrea in different ethnic groups 
in first Transvaal study
Titre Black White Coloured
Indian Total
1:16 
1:64 
1:128 
1:256 
1:512
36
26
11
1
1
62
13
4
0
0
92
14
8
2
1
18
6
1
0
0
208
59
24
3
2
Totals 
Sample size 
Percentage +ve
75
255
29
79
236
33
117
272
43
25
43
58
296
806
37
TABLE 5.2. Toxoplasma IFA titres for different age groups 
" in first Transvaal study
Titre
0-20
Age (years)
21-30 31-40 41-50 >50 Unknown Total
1:16 
1:64 
1:128 
1:256 
1:512
Totals 
Sample size 
Percentage +ve
21 60 36 28 13 50
208
4 16 9 5 3 22 59
6 2 3 2 3 8
24
0 0 1 0 0
2 3
0 0 0 1 0
1 2
11 78 49 36 19 83 296
102 225 128 79 54 218
006
30 35 38 46 35 38
37
TABLE 5.3. Prevalence of TOXOpuiBma anticuuxca •*.**  ...
groups in first Transvaal study - age differences
Age group White Black
0-20 16% (13)* 17% (49)
21-30 31% (51) 26% (73)
31-40 48% (23) 18% (22)
41-50 44% (18) 14% (5)
>50 * 27% (22) 17% (6)
Sample size in brackets
Coloured
43% (23) 
42% (84) 
39% (80) 
47% (55) 
43% (21)
Inaian
79% (15) 
47% (17) 
100% (3)
(1)
60% (5)
TABU. 5.4. Toxoplasma I FA titres in first Transvaal study - sex differences
Titre
1:16 
1:64 
1:128 
1:256 
1:512 
Totals 
Sample size 
Percentage +ve
TotalUnknownMa leFemale
In this survey, the highest prevalence was in Indians (58%), 
although the sanpie size was only 43. Prevalence in Blacks and Whites 
showed no significant differences, but significant differences were 
found between thi prevalence in these 2 groups combined and the preva­
lence in Colour® Is vp< 0.005) and in Indians (p < 0.001) (Table 5.1).
IFA ti^res 1 i the different age groups showed an increase from 30% 
under the age of 20 years to 46% in the 41-50 year group. The over 
50-year group had a prevalence of 35% (Table 5.2).
The prevalence in malts (39%) was consistently but not significantly 
higher than in females (35%).
Twenty-nine sera from Whi.es were collected from cat-show exhibitors, 
and 16 (55%) were positive, but the numbers in this group were too small 
for meaningful analysis.
As part of tho screening survey for congenital toxop asmosis in 3 
Johannesburg Hosp.tals, 6705 patients were tested at delivery. These 
patients consisted of 2001 Whites at the Queen Victoria maternity 
Hospital, 3659 Bltcks at the Baragwanath Maternity Hospital, and 901 
Coloureds and 144 Indians at the Coronation Hospital. Twenty-two per­
cent of these patients were seropositive (1473/6705) as shown in Table 
5 5, and the age distribution in 5680 ol these patients is shown in 
Table 5.6 and distribution of titres in Table 5.7.
The Black, Co oured and Indian groups had practically no differences 
in prevalence v25\), which wan significantly higher than that found in 
Whites (14%) (p < 0.001). Prevalence 'n all groups rose with age.
TABLE 5.5. Ethni: distribution of maternity patientf with positive 
I FA tests in "I Transvaal hospitals
Race to. Positive Percentage Sample Size
Positive
White 286 14.3% 2001
Coloured 2 36 26.2% 901
Indian 36 25.0% 144
Black 915 25.0% 3659
TOTAL 1473 22.0% 6705
TABLE 5.6. Age distribution of maternity patients 
with positive IFA tests in 3 Transvaal 
hospitals
QUEEN VICTORIA HOSPITAL
Age (yrsj
20
21-25
26-30
31-35
35
No. Positive Sample Size Percentage
Positive
11.5%
13.7%
19.0%
22.6%
26.3%
TOTAL 257 1733 14.8%
CORONATION HOSPITAL
< 20 51 249 20.5%
21-25 /8 318 24.5%
26-30 52 161 28.7%
31-35 20 61 32.8%
> 35 19 54 35.2%
TOTAL 220 863 25.5%
BARAGWANATH HOSPITAL
< 20 171 859 19.9%
21-25 282 1180 23.9%
26-30 189 647 29.2%
3i-35 71 217 32.7%
> 35 65 181 35.9%
TOTAL 778 3084 25.2%
Bjl TOTALS
< 20 299 1780 16.8%
21-25 438 2067 21.2%
26-30 300 1139 26.3%
31-35 119 402 29.6%
> 35 99 292 33.9%
TOTAL 1255 5680 2 2.1%
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The results of both Transvaal surveys were combined and are shown 
in Table 5.8 and Fig. 5.1 according to age and ethnic group. The 
difference in prevalence between Whites and the other ethnic groups 
combined was significantly different (p < 0.001), and between Blacks 
compared with Coloureds and Indians was also significantly different 
(p < 0.001). The percent annual seroconversion rate, using figures 
calculated by Frenkel (1973a) was 1%.
TRANSVAAL
y
0 5%
AGE (YEARS)
------------- BLACK
_______ WHITE
................ COLOURED a  INDIAN
________ TOTAL
Fig. 5.1. Prevalence of Toxoplasma antibodies in the Trantvaal. The 
shaded area indicates expected antibody prevalence at annual seroconver­
sion rates of between 0.5 and 1%.
PERCENT 
ANNUAL 
SEROCONVERSION
TABLE 5.8, Prevalence In the Transvaal of persons with
positive IFA tests according to age and ethnic 
group - combined Transvaal studies.
Ethnic Age (years1
Group ' -20 21-30 31-40 41-50 >50 Total
White
Black
Coloureds 
& Indians
12% (685)* 
20% (908)
25% (287)
16% (931) 
26%(1900)
29% (600)
26%(204) 
33%(420)
38%(198)
44% (18) 
14% (7)
46% (56)
27%(22) 
17% (6)
46%(26)
16%(1860) 
25%(3241)
31%(1167)
TOTAL 18%(1880) 24% (3431) 3 3%(822) 43% (81) 35%(54) 23%(6268)
Sample sizes given in brackets
5.2.2 Natal
In this survey, 30% of 635 sera were positive in the IFA test, and the 
ethnic and age group distribution of results are shown in Table 5.9 
and Fig. 5.2. The difference between the prevalence in Whites compared 
to that in Blacks and Indians is significant (p < 0.01). The percentage 
annual seroconversion rato in Whites was about 0.75%, while in the other 
groups it waa almost 2%.
TABLE 5.9. Prevalence of Toxoplasma antibodies in Natal by age 
and ethnic group
Ethnic
Group 0-20 21-30
Age (years)
31-40 41-50 >50 Total
White 9% (23)* 24%(83) 19% (59) 21%(47) 40%(45) 24%(257)
Black 30%(110) 40%(68) 27% (30) 50% (8) 80% (5) 34%(221)
Indian 28% (43) 34% C4) 45% (31) 13% (8) 100% (1) 34%(157)
TOTAL 27%(176) 32%(225) 28%(120) 24% (63) 45%(51) 30% (635)
Sample sizes given in brackets
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Fig. 5.2. Prevalence of Toxoplaama antibodies in Natal.
5.2.3 Eastern Cape 
The overall prevalence in this region was 24% in the 970 sera tested, 
and results are shown in Table 5.10 and Fig. 5.3. Again the difference 
in prevalence between Whites and the other groups is significant
(p < 0.001) .
PERCENT 
ANNUAL 
SEROCONVERSION
TABLE 5.10. Prevalence of Toxoplasma antibodies in the
Eastern Cape by age and ethnic group
Ethnic
Group 0-20
White 21% (241*
Black 20%(551
Coloured 45%(291
21-30
12%(1511 
28% (971 
23%(131)
Age (years) 
31-40
14%(105) 
36% (641
30% (831
TOTAL
I
CL
£
27%(1081 20%(379) 25%(252)
* sample sizes given in brackets
41-50 >50 Total
21%(84) 31%(26) 17%(400)
29% (31) 50%(18) 30%(265)
35%(49) 23%(13) 29%(305)
27%(164) 34%(67) 24% (970)
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Fig. 5.3. Prevalence of Toxoplasma antibodies in the Eastern Cape.
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/5.2.4 Western Cape 
The overall prevalence in this region, which has mainly Whites and 
Cape Coloureds, was 18% of 683 sera tested, and results are shown in 
Table 5.11 and Fig. 5.4. Again the prevalence in Whites is signifi­
cantly lower than in Coloureds (p < 0.001), but the percentage annual 
seroconversion over the age of 20 years is extremely low, unlike tne 
other regions where this continues to rise with age.
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Fig. 5.4. Prevalence of Toxoplasma antibodies in the Western Cape.
Age (years)
Ethnic 0 .J0 21-30 31-40 41-50 >50 T ° "
Group u .^u _ ____ _______ —  —
z : =: =  « • "
TOTAL
T ^ T .  1BM.07, .94(521 .54.41. .84,683.
Sample sizes given i.i brackets   ________
5 2 5 South West Africa and_Botswana
■SB*
( p  < 0 • 0 0 1 ) •
Ethnic Group
% Positive Sample Size
San
IKung - Tsumkwe 
IKuiig - Dobe 
!xb and jhui 
G/wi and (V ana
6%
9%
9%
1 2%
275
186
82
182
725
i „ '**Total San ?7
Dana
White
TOTAL
27%
12%
1 1 %
261
1063
*2
73.
TABLE 5.13. Prevalence of Toxoplama antibodies by age and 
ethnic group in South West Africa and Botswana 
(ages were available in 700 of the 1063 sera 
tested, and were not known for the Dama)
Ethnic Age (years)
Group 0-20 21-30 31-40 11-50 >50 Total
White 9% (35)* 9% (95) 9%(54) 12%(34) 23%(39) 12%(257)
San 5% (151) 7%(111) 10%(80) 16%(57) 14%(44) 9% (443)
TOTAL 6%(186) 8%(206) 10%(134) 14%(91) 18%(83) 10%(700)
* Sample sizes given in brackets
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Fig. 5.5. Prevalence of Toxoplama antibodies in South West 
Africa and Botswana.
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Fig. 5.6, Prevalence of Toxoplasma antibodies In South West Africa 
and Botswana. Figure;: show percentage seropositivity.
5.2.6 Orange Free State 
This area has been surveyed by Brink et a l .  (1975) and their results 
are given to complete the pictuie in South Africa as they used similar 
mcvhcds. Table 5.14 and Fig. 5.7 show the prevalence according to age 
and ethnic group. Differences between the groups are not significant.
TABLE 5.14. Prevalence of Toxoplasma antibodies by age 
and ethnic group in the Orange Free State 
(as reported by Brink e t a t . ,  1975)
Ethnic
Group 0
Age (years) 
-20 21-30 31-40 >40 Total
White 8% (85)* 14% (95) 5% (22) - 10%(202)
Black 4% (51) 6%(111) 16% (45) - 8%(207)
Coloured 11% (57) 9%(107) 25% (36) - 13%(200)
TOTAL 8%(193) 101(313) 17%(103) - 10%(609)
* Sample sizes given in brackets
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Fig. 5.7. Prevalence of Toxoplaem antibodies in the Orange Free 
State
5.2.7 Overall Pattern in Southern Africa 
The overall picture in Southern Africa i« shown in Tables 5.15 and 5.16 
and Figs. 5.8 to 5.11. The overall prevalence is 21%, with the percen­
tage annual seroconversion rate being about 1% up to the age of 25 years, 
and "ailing to 0.5% thereafter (Fig. 5.8). The overall prevalence
7 6 .
T A B L E  5 . 1 5 . P r e v a l e n c e  o f  Toxoplaama a n t i b o d i e s  i n
S o u t h e r n  Africa a c c o r d i n g  t o  r e g i o n
Region Percentage
positive
Sample
size
Percentage annual 
conversion 
<20 yr group >30
sero- 
yr group
Natal 30% 635 2% 1%
Eastern Cape 2't 970 0.8% 0.5%
Transvaal 23% 6268 1% 1%
Western Cape 18% 633 0.7% 0.1%
South West Africa 11% 1063 0.5% 0.3%
and Botswana 
Orange Free State* 10% 609 0.5% 0.5%
TOTAL 21% 10228 1% 0.5%
* Figures for the Orange Free State from Brink et al., 1975i.
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Fig. 5.8. Prevalence of Toxoplaama antibodies in Southern frica
- total nil regions.
according to region varies from 10% in the Orange Free State to 30% in 
the Transvaal, with annual incidence rates varying from just below 0.5% 
to 1% (Fig. 5.9]. Analysis according to ethnic group shows prevalence 
and incidence to be lowest in the San, intermediate in Whites and 
highest in Blacks, Coloureds and Indians (Fig. 5.10). Prevalences in 
Whites and San are significantly different from those in the other 
ethnic groups combined (p < 0.001).
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Fig. 5.9. Prevalence of Toxoplaema antibodies in Southern 
Africa according to region.
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T A B L E  5 . 1 6 . P r e v a l e n c e  o f  Toxoplasma a n t i b o d i e s  i n
S o u t h e r n  A f r i c a  a c c o r d i n g  t o  e t h n i c  g r o u p
Ethnic Group Percentage
positive
White
Black
Coloured & Indian 
San
TOTAL
16%
25%
28%
9%
2 1%
Sample
size
3294
4015
2194
725
10228
TOTALS-ETHNIC
Percentage 
annual sero­
conversion
0.5%
1%
1 %
0.3%
0.5-1%
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Fig. 5.10. Prevalence of Toxoplasma antibodies in Southetn Africa 
according to ethnic group.
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Fig. 5.11. Prevalence of Toxcpiaema antibodies in Southern 
Africa according to ethnic group and region
5.3 Discussion
South Africa occupies the southernmost portion of the African continent, 
from latitudes 22GS to 35°N, and from longitudes 17°E to 33°E. The 
country has a surface area of 1 178 679 knv 1456 000 square miles), and 
consists of 4 provinces, the Cape Province, Orange Free State, Natal 
and the Transvaal. Most of the country is subtropical except for the 
extreme north, which is in the tropics (South African Department of 
Information, 1978) .
The surface of South Africa consists of an interior plateau, with a 
mean altitude of 1 200 m (4 000 ft), surrounded by a coastal margin.
Climatically, South Africa has a warm temperate climate, with rain­
fall occurring more abundantly on the east coast due to the warm east
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Fig. 5.11. Prevalence of Toxoplasma antibodies in Southern 
Africa according to ethnic group and region
5.3 Discussion
South Africa occupies the southernmost portion of the African continent, 
from latitudes 22°S to 35°N, and from longitudes 17°E to 33o e . The 
country has a surface area of 1 178 679 km-’ (456 000 square miles) , and 
consists of 4 provinces, the Ct.pe Province, Orange Free State, Natal 
and the Transvaal. Most of the country is subtropical except for the 
extreme north, which is in the tropics (South African Department of 
Information, 1978).
The surface of South Africa consists of an interior plateau, with a 
mean altitude of 1 200 m (4 000 ft), surrounded by a coastal margin.
Climatically, South Africa has a warm temperate climate, with rain­
fall occurring more abundantly on the east coast due to the warm east
coast Agulhas current and the cold west coast Benguela current. The 
elevated interior plateau results in lower mean temperatures than is 
normal for the latitude. Average annual rainfall for South Africa is 
464 mm (world mean 857 mm), with 20% receiving less than 200 mm.
Mean annual temperatures are fairly uniform throughout the country, 
but can occasionally reach —12 C inland. Maximum temperatures 
of 32°C are common in summer along the Orange River Valley and the 
Transvaal Lowveld. There is, however, generally very little seasonal 
temperature change compared to that in Europe and North America.
Humidity is generally very low in the interior but is high over 
the coastal margin, particularly the east coast. The interior of the 
country is generally dry and there is a high rate of evaporation 
leading to very little discharge of water into rivers.
Five natural vegetation areas occur in South Africa. Desert or 
semi-desert is found along the west coast and most of the western 
interior (Karoo). Mediterranean vegetation occurs in the Cape Peninsula 
eastwards to Natal. Bushveld (savanna) covers large areas of the 
interior (Transvaal and Northern Cape) and temperate grassland covers 
large areas of the southern Transvaal and Orange Free St. c .
Sovth West Africa (SWA) is a sparsely populated desert-like area to 
the south-west of South Africa, with an area of 824 269 kr/ (318 260 
square miles). The country is dry and arid, with few perennial rivers, 
and most of the territory consists of desert or semi-desert. The Namib 
Desert constitutes about one fifth of SWA, and the Kalahari Desert covers 
the northern and eastern areas. There is virtually complete absence of 
surface' water. Rainfall varies from less than 100 mm to 400 ram per year, 
and there is a very h<yh rate of evaporation.
The population o South Africa (1976 estimate) is 23 761 000, con­
sisting of 18% White, 69% Black, 10% Coloured and 3% Asian. Birth rates 
for Whites are about 19 per 1 000, and for the other ethnic groups about 
28 per 1 000.
The population of South West Africa is 762 000 (1976 estimate), with 
12% White, 80% Black, 2% Coloured and 3% San (Bushman).
The overall prevalence of Toxoplama antibodies in Southern Africa 
was found to be 21%, varying from 30% in Natal to 10% in the Orange Free 
State (Table 5.15). The percentage annual seroconversion rate overall 
dropped from 1% in the under 20-year age group to 0.5% in the over 30-
year age group. Prevalence rose with age in all areas except for the 
Western Cape, where there was a much lower rate of increase over the 
age of 20 years t^an in the other areas. This occurred in both Whites 
and Coloureds, and appears to reflect a regional diffeience in 
acquisition of infection. The slow rate of increase could be caused by 
oocyst transmission being more important than meat, with resultant 
infections occurring mainly in childhood, and very little t. i^k ot 
infection during childbearing age.
Prevalence overall also varied with ethnic group, from 9% in the 
San to 28% in Coloureds and Indians. Annual seroconversion rates rose 
consistently with age in all ethnic groups, and the variations found on 
a regional basis are therefore probably due to regional rather than 
ethnic factors. In general, prevalence was lowest i, - the hottest, driest 
areas luch as South West Africa and Botswana, and highest in the most 
hum I- < and wetter . areas such as Natal. However, in all areas, prevalence 
in ... it.es was alrayi. lower than that in Blacks, Coloureds and Indians, 
indicating greater exposure of these groups to infection. The reason for 
this difference is probably socio-economic, and could reflect greater 
exposure to oocysts shed by stray cats. Exposure to raw or undercooked 
meat would be expected to be higher in Whites, and this does not therefore
seem to be a major factor in South Africa.
The overall pattern of toxoplasmosis in man in Southern Africa shows 
a fairly low prevalence arid incidence of infection. Prevalence is 
generally highest in the hottest and wettest areas, and lowest in arid 
areas. Prevalence i also lower in Whites than in Blacks, Coloureds 
and Indians, probably due to socio-economic or cultural factors.
With annual birth rates of 19 per 1 000 for Whites and 28 per 1 000 for
other ethnic groups, the estimated annual number of White births would be 
81 260 and of other ethnic groups 545 530. The overall annual incidence 
of acute toxoplasmosis in the childbearing ag.; group is about 1%. The 
expected number of mothers developing acute uoxoplaamisis during preg­
nancy per year, using 0.75% incidence to cover the 9 months gestation 
period, would therefore be just over 600 Whites and 4000 of other ethnic 
groups. If, as has been found in France, 40% of maternal infections 
resulted in foetal infection, and 6% in serious foetal disease, the 
expected annual numbers of congenital infections would be 240 in Whites 
and 1 600 in other groups, with 36 severe cases in Whites and 240 in other
groups. Very little Information is available as to whether these 
estimates could be correct, but from the number of cases diagnosed 
and/or reported, it would seem that either the number of severe congeni­
tal cases is much lower than the numbers expected, or that the cases are 
not being correctly diagnosed.
At the Baragwanath Hospital, for example, only 2 cases of severe 
congenital toxoplasmosis have been diagnosed over a 3-year period, 
during which there were about 45 000 births at the hospital. The 
expected number of maternal infections would be 338, with 20 severe 
infections. As most patients with congenital 1 ifections are investi­
gated fully with good laboratory services available, it is unlikely 
that severe cases would be consistently missed, and the possibility of 
local strains being of low virulence must be considered. Further 
evidence of the low virulence of local strains will be presented in 
Chapter 7.
6.0 REPORTS np rtSF.S OF CONGENITAL MJr. trpUIRED TOXOPLASMOSIS
Daring the period In which prevalence studies were being conducted, I 
was consulted on many occasions regarding case, of suspected cong.nl.a! 
or acquired toxoplasmosis. However, in most of these cases the 
diagnosis of toxoplasmosis was not substantiated, and only 6 definite 
ToxopUxma Infections (2 congenital and 4 acquired) were seen.
6.1 Congenital cases 
Two patients with symptomatic congenital toxoplasmosis hale been seen
at the Baragwanath Hospital.
Case 1
A Black female Infant hern in May 1975, birth weight 1.75 kg, present, 
at birth with prematurity (34 weeks) and hydrocephalus, and required 4 
weeks' hospitalization. The mother had not attended antenatal clinic 
and gave no history of Illness during pregnancy. An older sibling was 
well. After discharge, the mother did not return for follow-up visits, 
end only sought medical attention again 3 years later. In June 1973.
At this time, the mother stated that he child had not been moving her 
right limbs as well as her left ones for some months. The child's
milestones had been normal.
on examination, the child was alert, and both height and weight
were below the third percentile. There was asymetrical hydrocephalus, 
with the right temporal area being very prominent, and the left temporal 
and occipital areas being flattened. There was bilateral microphthalmia, 
a left convergent strabismus, and nystagmus. The fundi showed bilateral 
optic atrophy with pigmented areas of retlnochorolditls. Estimated 
mental age on testln, ,responded to that of a 2-y ar old. The child's 
right limbs showed mulctLar atrophy, increased tone and tendon reflexes, 
and weakness. Sensation and coordination were intact.
Investigations showed the following:
Cerebrospinal fluid - 3 lymphocytes/nl, protein 38 mg/100 ml, glucose
51 mg/10w* ml.
Skull x-ray - bilateral periventricular calcification and copper-beaten 
appearance of raised Intracranial pressure (fig. 6.1).
rig. 6.1. Skull X-ray of case 1, showing 
bilateral periventricular calci­
fication and copper-beaten 
appearance of raised intra­
cranial pressure.
R
Fig. 6.2. Computed skull tomogram of case 
1, showing hydrocephalus of the 
right lateral and the third 
ventricles, with a focus of 
calcification adjacent to the 
right lateral ventricle.
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Computed skull tomogram - marked hydiocephalus of right lateral and 
third ventricles, with a focus of calcification adjacent to the 
right lateral ventricle (Fig. 6.2).
Serology
Toxoplasma - IFA 1:512
IgM-IFA 1:32 
CFT 1:8
Cytomegalovirus, rubella and syphilis - all negative.
Maternal serology
Toxoplasma - IFA 1:512
IgM-IFA 1:32 
CFT 1:16
In view of these results at the age of 3 years, the diagnosis of 
congenital toxoplasmosis was made. The classical triad of hydrocephalus, 
intracranial calcification and rotinochoroiditis with serolo / indi­
cative of recent infection in both mother and child makes the possibility 
of another cause highly unlikely.
Case 2
A Black male infant was born on 1 March 1977 at the Baiagwanath Hospital 
at about 28 weeks' gestation with a birth weight .'-f 1.14 kg. The mother 
had not attended antenatal clinic. The baby was in very poor condition 
at birth and died 8 hours later with features of respiratory distress.
The baby was born during the period in which the survey for congenital 
toxoplasmosis described in Chapter 7 was being conducted and maternal 
and cord blood were submitted for Toxoplasma serolc v, and results were 
as follows:
Maternal: IFA 1:65536
IgM-IFA 1:16 
CFT 1:16
Baby: IFA 1:32768
IgM-IFA 1:64 
CFT 1:16
A specimen of placenta was not submitted for examination.
An autopsy was not performed when the baby died, and the child was 
buried. When the serology result was known on the next day, the diag­
nosis could therefore not be confirmed pathologically. However, in
view of the premat’ re delivery, revere nature of the infant's diser.se 
and positive sero1ogy including positive cord blood IgM-IFA test, the 
diagnosis of congenital toxopla mopis is extremely like.y to be correct. 
Serology for cytomegalovirus, rubella and syphilis on maternal and cord
sera wi re all negative.
6.2 Acquired cases 
Four patients with Toxoplasma lympnadenxtis have been seen over the 
period 1975 to 1978. In all cases, the diagnosis was made when lymph 
node biopsies were performed to exclude malignancies and the histologic 
features of Toxoplasma lymphadenitis were noted. The diagnoses weic 
confirmed in all cases by positive aerology and direct immunofIncres­
cent staining of lymph node sections with conjugated antL-Tcxoplasma 
serum as described in Chapte’ f
Case 1
A 25-year o' _ White male, livxi.g in the Transvaal, presented in June 
1975 with a single painless anterior cervical lymph node which had 
gradually enlarged in size over the previous 2 months. The node was 
excised and t,.e diagnosis made on the histological appearance together 
with posit ivt* serology. The patient's dye test titre was 1:1024, I FA 
and IgM-IFA were both positive but end titres were not decemined, and 
the CFT was negative. Direct immunofluorescence on node sections 
performed sone time later was also positive. The patient was given a 
month's course of pyrimethamine (25 rag/day) and triple suIphon&mides 
(4 g/dayl, and has been wall since.
Case 2
A 30-year old Chinese male, living in Botswana, presented in mid-February 
1977 with a history of noticing painless right cervical lymphadenopathy 
developing over the previous week. During the first few days of that 
month, the patient had prepared beef biltong from a freshly-slaughtered 
animal purchased from a local btcher. The meat had not been frozen 
and was handled by the patient but not by his wife.
An anterior cervical node was excised cn 2.! February to exclude 
malignancy, and Toxoplasma lymphadenitis was diagnosed histologically. 
Serology was then performed, and the results of repeat testing ovci the 
next 14 months are shown in Fig. 6.3. Peak IFA titre was 1:512000, peak 
IgM-IFA titre 1:2048 and peak CFT titre 1:32. Direct immunofluorescence 
on lymph node sections was also positive.
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Fig. 6.3. Serology on case 2 of acquired Toxoplasma lymphadenitis.
IFA, IgM-IFA and CFT titres were determined over a 14- 
inonth period after presentation.
The patient wcs given a 2-week course of pyrimethamine and triple 
'p;,-„Kunides, and has remained well during the follow-up period, 
on,is patient may have contracted his infection from handling the 
beef he used to make biltong. After the meat had been salted and dried 
for several days, it was eaten by the patient and his wife and child.
Only the patient developed acute infection, while his wife and child 
remained seronegative. Preparation of biltong would be expected to kill 
Toxoplasma cysts (Work, 1971), and the only time the patient had recently 
handled food was when he had prepared the biltong. Transmission there­
fore probably occurred during handling of the fresh meat as the other 
persons wno ate the biltong did not become infected.
C x s > i 3
A 30-year old White female, living in the Transvaal, prerented in 
January 1978 with a 2 month history of bilateral painless posterior 
cervical lymphadenopathy. A lymph node biopsy was performed to exclude 
malignancy, and a histological diagnosis of toxoplasmosis was made.
The patient's Toxoplasma serology was then performed - the IFA titre 
was 1:4096 and the Ig.-l-IFA test was positive. Lymph node direct Immuno­
fluorescence was also positive. The patient was not treated and nas 
been well on follow-up.
Case 4
A i9-year old White male, living in the Transvaal, presented in June 
1978 with 2 painless lymph nodes in the right supraclavicular area, 
which had developed over the previous few weeks. The nodes persisted 
after a course of antibiotics, and a lymph node biopsy was performed.
The histological -cport of tne biopsy suggested toxoplasmosis as the 
diagnosis, and the patient's Toxoplasma serology was done. The IFA 
titre was 1:16000 with a positive IgM-IFA test. Four months later the 
IFA titre was 1:2000. Lymph node direct immunofluorescence Wcu positive. 
The patient received a course of pyrimethamine and suIphonamides, and 
has remained well on follow-up.
These 4 cases illustrate typical acute toxoplasmic Lymphadenitis 
presenting only with asymptomatic cervical lymphndenopc.thy (Table 6.1). 
The patients presented to different practitioners, and in none of these 
patients was the diagnosis considered before lymph node excision biop­
sies were performed. Serology for toxoplasmosis was not performed on 
any of these patients prior to biopsy, and requests to attempt isolation 
of the parasite were therefore not made. Awareness of Toxoplasma as a 
cause of lymphadenitis couir* have enabled the diagnosis to have been 
made prior to surgery, an surgery probably avoided in these cases.
Three of the 4 cases were treated, although the ntcessi' v for treatment 
of such cases is doubtful. (Remington, 1974).
The use of direct immunofluorescence has been useful in confirming 
the diagnosis in these cases, but care must br taken to ensure that false 
positive results are not obtained (Frenkel and Piekarski, 1978). This 
was done by absorbing out the direct conjugate as described in Chapter 4, 
and no fluorescence was obtained with the conjugate after absorption in 
these cases.
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7.0 TOXOPLASMOSIS DURING PREGNANCY IN SOUTH AFRICA
The complete lack of data on the incidence of toxoplasmosis during 
pregnancy and on congenital infection in South Africa prompted my 
investigation into the incidence of toxoplasmosis during pregnancy.
From vhe fairly low prevalence of toxoplasmosis in the initial sero­
logical surveys, and the small number of congenital cases reported in 
the South African literature, toxoplasmosis should not be a major hazard 
during pregnancy in South Africa. However, no data were available to 
substantiate this assumption. The public health significance of 
definite data on this assumption is important in deciding whether 
screening for toxoplasmosis during pregnancy would be indicated.
To answer these questions, I undertook a study of the incidence of
acute toxoplasmosis during pregnancy, and on foetal transmission, during 
the period 1975 to 1977 in 3 Johannesburg hospitals, covering all ethnic 
groups. For this study, I was awarded a 3-year grant by the South 
African Medicar Research Council to cover the laboratory costs involved.
7.1 Patients an I Methods 
Patients were selected at random on hospital presentation for delivery,
and specimens of maternal blood, cord blood, and placenta in anti­
biotic-containing saline were requested. Maternal blood specimens were 
obtained easily, but cord blood and placenta were not always submitted. 
Maternal and cord blood sera were tested by the IFA method on receipt, 
and if positive at *1:1024, placenta if submitted was inoculated into 
mice. If only maternal blood was submitted^ a blood sample was obtained 
from the infant within 3 oays of birth if the maternal IFA was *1:512.
All eera positive in the IFA test were then tested by the CFT and all 
sera with IFA titres *1:512 or CFT positive at any titre were tested by 
the IgM-IFA test.
During the 6-month period before the study started at each hospital, 
sera from antenatal patients were submitted whenever routine venepunctures 
were performed and stored at -20°C. At delivery patients were checked 
for the presence of stored sera, and if available, stored se~a were 
tested together with the delivery specimens. This system worked well at 
the Queen Victoria Hospital, where stored antenatal sera were available
for 92% of patients with positive IFA test at delivery, but less well 
at coronation Hospital (56%) and Baragvanath Hospital (lu%) as many 
patients did not attend antenatal clinic or antenatal sera were not 
submitted for storage. A further problem encountered at Baragwanath 
Hospital was that difficulty was experienced in obtaining staff co­
operation in submitting cord blood and placenta specimens. However, in 
the few maternal sera without cord blood sera that had I FA t'.tres < ‘ 
*1:512, blood was obtained from the neonates within 3 days of birth.
Methods used for the IFA test, TgM-IFA test, CFT and mouse inocu­
lation are described in Chapter 4.
7.2 Results
Of the 6705 sera submitted from mothers at delivery, 14/3 (220 were 
positive at. titres of *1:16 in the IFA tent, as shown in Tables 7.1 
and 7.2. Prevalence of IFA antibodies was lowest in Whites (14.3.) and 
similar in Blacks, Coloureds and Indians (25 to 26%). The annual sero­
conversion rate was 1% overall, being about 0.75% in Whites and 1.2% In 
the other ethnic groups (fig 7.1).
TABLE 7.1 Distribution of maternity patients with positive 
IFA tests at delivery
Hospital Ethnic Group Fo.
Positive
Percentage
positive
Sample 
si ze
Queen Victoria White 286 14.3% 2001
Baragwanath Black 9i:( 25.01
3659
Coronation Coloured 236 26.21 901
Coronation Indian 36 25.0% 144
TOTAL 1473 22.0% 6705
Results were classified according to IFA titre and presence oi 
positive CFT and IgM-lFA tets. Criteria used (Table 7.3) were based 
on patients with chronic infection having IFA titres of up to 1:2048 
with negative CFTs and IgM-IFAs (1:32, patients with recent, infection 
having positive IFAs (titres of 1:32 to 1:512) with positive CFTa, and 
patients with evidence of definite or possible acute Infection during 
pregnancy ^reconverting or having high titre IFAs (*1:1024) with positive
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Fig. 7.1. Prevalence of Toxoplasma antibodies in maternity 
patients at delivery.
errs and IgM-IFAs. Patients with positive CFTs, classified as having 
recent infections (category 5), were assumed to have had their acute 
infection before their present pregnancy as titres were low (<1:312 IFA 
and <1:3.2 IgM-IFA) and, where antenatal sera were available, remained 
unchanged during pregnancy. It is possible, however, that a few of 
these patients • i early acute third trimester infections if antenatal 
sera were not available, but this group would be small and carry very 
little risk of symptomatic congenital infection.
TABLE 7.3 Criteria used to analyse patients with positive
---------- IFA tests and to define acute toxoplasmosis during
pregnancy. Patients fulfilling criteria 1 to 3 were 
regarded as definite cases, and criterion 4 probable 
cases of acute infection
Criteria No. of cases
1. Seroconversion from negative to positive _,1A,
IgM-IFA and CFT 3
2. Four-fold or greater rise in IFA titre in presence
oi or development of positive IgM-IFA and CFT 3
3. Single or penk titles of )1:2048 IFA, %1:64 IgM-IFA
and 51:16 CFT 4
4. Single titres at delivery of 1:1024 IFA with 51:16
IgM-IFA and %1:8 CFT, regarded as probable cases 10
5. IFA <1:512 with CFT 1:8 or 1:16 and IgM-IFA <1:32 
at delivery and no change in t;.tre during pregnancy 
(if antenatal sera tested), indicative of recent 
infection (within past 2 to 4 years), but probably
not during present pregnancy 89
6. IFA <1:2043 with CFT negative and IgM-IFA (if done)
<1:32 indicative of past infection 1364
Results were analysed according to these criteria, and are shown 
in Tabic1 7.4 to 7.6 according to iFA, IgM-IFA and CFT results and 
criteria given in Table 7.3. Overall, 22% )f patients 0473) had 
positive IFA tests, with 1.6% (109) fating positive CFTs. Eighty- 
nine of the patients with positive Cris were classified as having had 
recent infection but probably not during the present pregnancy, and 
20 were classified as having evidence of definite or probable acute 
infection during the present pregnancy. Detailed results on all sero­
positive patients are given in the appendices. Results on Whites from 
the Queen Victoria Hospital are given in appendix 1 (pages t'9 to 129), 
on Blacks from the Brragwanath Hospital in appendix 2 (pages 130 to 
154), and on Coloureds and Indians from the Coronation Hospital in 
appendix 3 (pages 155 tc 164).
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TABLE 7.6 Distribution of patients according to past, recent or acute infection
IFA titre Queen Victoria 
Hospital
1 2 3
Baragwanath
Hospital 
1 2 3
Coronation 
Hospital 
1 2 3
Total
2
Total of all 
IFA positives
1:16 87 - - 378 - - 95 - - 560 - - 560 8.4%
1:32 94 5 - 197 3 — 55 - - 346 8 - 354 5.3%
1:64 56 14 - 102 16 - 38 11 - 196 41 - 237 3.5%
1:128
1:256
14 7 - 86 12 - 31 2 - 131 21 - 152 2.3%
3 2 2 54 12 - 20 2 - 77 1-3 2 95 1.4%
1:512 1 - - 25 3 1 8 - 1 34 3 2 39 0.6%
1:1024 - - 1 13 - L 8 4 - 2 17 - 11 28 0.4%
1:2048 - - - 2 - - 1 - 1 3 - 1 4 0.06%
1:4096 - - ? - - - 2 - 1 - - 3 3 0.04%
>1:4096 - - • - - 1 - - - - - | 1 0.015%
TOTAL 255 28 3 857 46 12 252 15 5 1364 89 20 1473
Percentage
positive 12.8% 1.4% 0.15% 23.4% 1.3% 0. 3% 74.1% 1.4% o.5% 20.3% 1.3% 0.3% 22.0V
Sample
size 2001 3659 1045 6705 6705
1. IFA positive. CFT negative, indicative of past inf ition (category 6)*
2. IFA positive, CFT positive, both constant and/or in low titre (IFA (1:512; CFT (5:16), indicative
of recent infection (within past 2-4 years) (category 5)*
3. IFA positive, CFT positive, with evidence of definite or probable acute infection either by sero­
conversion or if IFA, IgM- FA and CFT are ’.igh (IFA 51:1024; IgM-IFA 51:16 ana CFT 51:8) 
(categories 1-4)*
*Se'« Table 7.3
98.
Total IgM levels were measured in ?29 3 cord blood specimen, 
from the Queen Victoria and Coronation Hospitals. IgM levels 
of <?0 lU/ml are regarded as normal in Whites and <100 lU/ml in Blacks. 
Values in Coloureds and Indians have not been reliably established, but 
from the results obtained, seem to have a similar distribution to that 
in Whites (Table 7.7). Cord blood IgM levels were <30 lU/ml in the cord 
blood of k abies of all the White, Coloured and Indian patients with 
definite or probable acute infection. Cord blood IgM levels were not 
determined in the remainder of specimens from White, Coloured or Indian 
patients, nor in any from Black patients.
TABLE 7.7. Cord blood total IgM levels
IgM
<30
level
30-
(lU/ml)
100 >30 TOTAL
Queen Victoria Hospital 
Coronation Hospital
1590 (86%) 
369 (83%)
236
67
(13%)
(15%)
22
9
(1%)
(2%)
848
445
TOTAL 1959 (85%) 303 (13) 31
(1.4%) 2293
Results on the 20 patients considered to have definite or probable 
acute infection during pregnancy are given in Tables 7.8 and 7.9.
Patients A2, A3 and C3 fell into category 1 (seroconversion), patients 
hi, Cl and C2 into category 2 (four-fold rise in IFA titre), patients 
B1 to B4 into category 3 (single IFA titre of *1:2043 with positive U-’T 
and IgM-IFA) and patients B5 to B12, and C4 and CS into category 4 
(single IFA titre of 1:1024 with positive CFT and IgM-IFA).
In White patients at the Queen Victoria Hospital, tu.e highest IFA 
titre obtained was 1:1024 in patient Al. This patient acquired her 
infection during the first trimester of pregnancy, and probably had a 
higher peak between 12 and 24 weeks when sera were submitted. Four 
months post-natal1" however, this patient's CFT was negative, giving 
a maximum period of ,er CFT being positive of 10 months.
Patient A2 seroconverted at about 34-weeks' gestation, and at delivery 
her IFA titre was 1:256 and CFT 1:16, giving the impression of a titre 
peak between 34 weeks and term. At : months follow-up, the CFT was 
negative, giving the period of the CFT being positive as less than 6
months.
Patient A3 also seroconverted in the third trimester, and on follow-up 
at 3 months was still CFT positive, but with an IFA titre of only 1:256.
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These 3 patients (A1 ind A3) had definite serologic evidence of 
toxoplasmosis during pregnancy, but peak IFA titre was 1:1024 ard peak 
CFT titre uas 1:16. These titres are surprisingly low, although titres 
could have risen considerably in between times when sera were tested.
Patient Bl had an IFA titre of 1:2048 and CFT titre of 1:32 at 32 
weeks, indicating infection probably during the second trimester.
Patient B2 had not attended antenatal clinic and at delivery had 
an IFA titre of 1:65536 and CFT titre of 1:16. This patient delivered 
at an estimated 28-weeks of pregnancy, and the baby's cord blood had 
similar TFA and CFT titres with a positive JgM-IFA in a titre oj? 1:64.
This child was the only case of symptomatic congenital infection detected 
in the pregnancy study, and further details of this child have been 
given in Chapter t. In view of the severe foetal disease and compara­
tively low CFT, infection was considered to have been acquired :.n the 
first half of pregnancy.
Patients B3 and B4 had IFA titres of 1:4096 at delivery with CFTs 
of 1:128 and 1:32, indicating probable third trimester infections.
Patients Cl and C2 both showed four-fold or greater rises in IFA titres 
with positive CFTs at delivery, and acquired their infections during 
the second and third trimesters respectively. Patient C3 seroconverted 
between 30 weeks ard term (third trimester), and had an IFA titre of 
):2048 at delivery. None of the babies of these patients had evidence 
of congenital infection.
The cases considered to have evidence of probable acute infection 
during pregnancy (B5 to B12, C4 and C5) did not have antenatal sera 
available. They all .\ad IFA titrei of 1:1024, CFT titres of 1:8 or 1:16 
and IgM-IFA titres of Is 16 to 1:512. Most patients with acute infection 
in other series had dyr> test titres of 21:1024, and this titre is con­
sidered significant by D'smonts and Couvreur (1974a), particularly if 
accompanied by a positive CFT and I#-IFA. Congenital transmission 
occurred in 1 of the 10 probable acute maternal infections, and this 
baby was asymptomatic (B12).
All cases of acute infection were followed up and 18 of the 20 mothers 
were traced and mothers and babies retested between 3 and 20 months after 
delivery. Ten mothers with IFA titres of *1:512 and positive CFTs were 
also followed up, as well as 12 mothers with positive IFAs and negative 
CFTs at delivery (Tables 7.10 and 7.11). The only congenital cases
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detected were the babies of patients B2 (which had died soon after birth) 
and ^12, which was asymptomatic but seropositive. All the other babies 
traced had I FA titres of <1:16 and negative CFTt. and IgM-IFAs. Two 
patients with probable acute infection during pregnancy could not be 
traced.
Only 1 mother (A2) had features suggestive of acute infection during 
pregnancy. She had an influenza-like illness with pyrexia, cervical 
lymphadenopathy and pharyngitis at. 32 weeks' gestation while on holiday 
in Durban. This patient seroconverted at 34 weeks' gestation, and her 
husband also had serological evidence of acuto infection, indicating a 
probable common source of infection.
Congenital transmission was therefore found in 2 out of 20 cases 
of acute infection during pregnancy (or 1 out of 10 definite and 1 out 
of 10 probable cases), giving a transmission rate of 10k.
The IgM-IFA results were useful in confirming IFA and CFT results 
indicative of acute infection, and titres were >1:16 in all definite or 
probable acute cases, and the highest titre seen was 1:512. Itie IgM-IFA 
was positive in cord blood of both babies with congenital infection, and 
negative in all other cord cloods tasted. It was the most useful test 
for detecting congenital infection as the cord blood CF r was often 
positive, although being negative on follow-up.
In the 89 recent infections (IFA and CFT positive), the I<yi -IFA was 
negative in 41 cases and positive (1:16 to 1:32) in the remainder. In 
patients regarded ao having had past infection with IFA titres of )1:u12, 
but negative CFTs, the IgM-IFA was positive (1:16 to 1:32) in 28 of the 
53 sera (53%), and some of these patients may have had recent infections. 
The correlation between the CFT and the IgM-IFA results was poor, 
probably as the IgM-IFA was only regarded as positive at titres of 
>1:16. This may have limited the use of the IgM-IFA, although the 
IgM-IFA was positive in low titre in about half the patients with T?A 
titres of >1:512 but with negative CFTs. Improved standardization of 
the IgM-IFA should result in mare reliable interpretation of this test.
7.3 Discussion
Frenkel (197 3a) has drawn up charts of the relationship between incidence 
and prevalence of toxoplasmosis (Fig. 7.2) and the r i s o f  maternal and 
fcetal infection during pregnancy in the 20- to 30-year age group 
(Fig. 7.3 and Table 7.12). The maximum incidence of maternal infections 
occur in areas with annual incidence rates of 3% to 5%. Where the
1 0 5 .
incidence is leas than 3%, infections during pregnancy occur less 
JUjI V/, „-h- MS® is over 5%^ ^ the majority of jjersom.^
would already be infected by the time they reached childbearing age, 
and infection during pregnancy would therefore be less common.
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Fig. 7.2. Theoretical toxoplasmosis incidence rates in different 
age groups according to prevalence of an* bodies (from 
Frenkel, 1973a).
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TABLE 7.*2. Theoretical calculated risk of maternal and foetal 
toxoplasmosis according to percentage annual sero­
conversion rate (modified from Frenkel, 1 >7 3a).
Percentage
annual
seroconversion
Maternal risk 
per 10 000 
pregnancies
Foetal risk per 
cies
40% foetal 
transmission
10 000 pregnan- 
with
10% foetal 
transmission
0.25 20 8 2
0.5 40 16 4
1 60 24 6
2 90 36 9
3 115 46 i2
5 110 44 11
7.5 70 28 7
This study has yielded a prevalence of Toxoplusma antibodies of 22%, 
with an approximate 1% annual seroconversion rate. Twenty maternal 
infections were detected with 2 congenital transmissions, giving a trans­
mission rate of 10%.
Problems were encountered in the detection of all cases of maternal 
infection due to the lack of antenatal attendance, late antenatal 
presentation, difficulty in detection of infections in very early and 
very late pregnancy, and the apparent short period in which titres
remained at high levels.
The IFA and IgM-IFA tests appeared to give good reproducible results, 
but the CFT gave many technical problems. With adequate standardization, 
the IgM-IFA should replace the CFT, although their results do not always 
coincide. The IgM-IFA was y rticularly useful in the early detection of 
congenital infection as the CFT in cord blood we.s often positive in the 
absence of congenital transmission.
Using the factors presented above and the results obtained in this 
study, with a 1% annual incidence, 60 new infections per 10 000 pregnan­
cies would be expected in the populations studied. This study in general 
did not take abortions into account, and infections in early pregnancy 
could have been missed in patients only tested at delivery. Therefore 
assuming that evidence of infection during the second and third trimesters 
was detected, 40 infections per 10 000 pregnancies should be detected 
under the study conditions used. As 6705 patients were studied, the 
expected number of acute infections is 27, with 11 expected congenital 
infections at a 40% transmission rate.
The number of acute infections detected was 20, the difference 
probably being due to patients not tested antenatally being missed. Only 
2 of the babies born to these 20 mothers had serological or clinical 
evidence of congenital infection at birth, and follow-up on 1C of the 
remaining 19 of these babies confirmed the absence of congenital infection. 
Follow-up examinations included serology on mothers and babies and physical 
examination of babies, including fundoscopy by an ophthalmologist.
These results have shown the number of maternal infections to be 
approximately that expected, but that the foetal transmission rate was 
much lower than expected (10% instead of 40% found in France). This trans­
mission rat : is particularly low as most of the infections detected were 
in the second and third trimesters, where transmission rates are known to
bo even higher. It is particularly interesting, also, to note that only 
one asymptomatic case was detected, and that organisms could not be 
recovered from the pla'centas of 14 of the mothers with acute infection 
(the placentas of the congenital cases were unfortunately not submitted).
The results obtained it. this study were compared with those obtained 
in other studies, as shown in Table 7.13. These studies are difficult 
to compare as most had the same problem as encountered in this study of 
inadequate serology during early pregnancy. This is clearly shown in 
the percentage of actual to expected acute maternal cases, which was 47% 
to 77%, except xn the study by Desmonts and Couvreur (1974a), where the 
fi.pi-e was 93%, apparently as in France women have to attend antenatal 
clinics by the end of the first trimester of pregnancy to obtain welfare 
uenefits. However, the expected number of maternal infections in preg­
nancy calculated according to Frenkel's data (Figs. -.2 and 7.3) appears 
to be remarkably accurate considering the techniques used and the actual 
number of cases detected. Although some of the estimates shown in Table 
7.12 could be question, d, all the studies should have detected congenital 
infections with sero'.o,ic evidence of infection at birth or on follow-up. 
Therefore the congenital infection rate per pregnancy should give the 
most reliable index of transmit,tun rates during pregnancy. This rate 
was h.ghest in France (0.4'), around 0.1% in Nor,.’! America and less than
0.05% in England and in the present study.
The transmission rate found in France of 40% has been assumed to be 
valid in other parts of the world. However, from this and the other 
studies considered, this transmission rate docs not appear to be vali 
elsewhere. Actual transmission rates in other studies varied from 0 to 
21%, and expected transmission rates from 0 to 16%. Transmission rates 
in the 3 North .xmerican studies were 13 to 21%. This study showed a trans­
mission rate of 10% in South Africa.
From the above comparisons, definite differences in congenital infection
and congenital transmission rates are found in different parts of the world, 
raislna the question of the factors responsible for these differences. 
Differences in strain virulence in different parts of the world could 
explain these variations, with strains in England and South Africa appar­
ently being of particularly low virulence. Factors such as infective dose, 
nutritional status, host genetic response to infection and host immunity 
do not appear to be responsible for these differences. The variations in
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virulence may affect the ability of organisms to cross the placenta, as 
symptomatit conconitaJ infections, when they do-occur, appear to cause 
as much damage to the foetus in areas of high and lew foetal transmission 
rates. Comparison of Toxoplasma strains from these different areas may 
clarify the reasons for these differences.
8.0 TOXOPLASMOSIS IN SHEEP IN SOUTH AFRICA
Very little has been published on the prevalence of toxoplasmosis in 
domestic meat-producing animals in South Africa, and the only data 
available showed that all of 20 cattle, 16 of 20 pigs and 7 of 10 sheep 
were dye-test positive (SATMR, 1959). When material from sheep became 
available during 1977 from the abattoir of the Onderstepoort Veterinary 
Institute, Pretoria, this was used to investigate the role of these 
animals in toxoplasmosis.
8 .1 Materials and methods 
Sheep, bred tor slaughter on farms in the Transvaal, Orange Free State 
and Northern Cape, were received by the Onderstepoort Veterinary Research 
Institute, and slaughtered by severing the carotid and jugular vessels.
The origin of individual animals could not be determin 1 as they were 
pooled by stock agents prl to despatch to the abattoir. Blood was 
collected in a large vessel from the severed neck vessels, and serum 
separated and inactivated. From some animals, the diaphragm was removed 
and placed in antibiotic-containing saline. Serum was collected from 695 
animals, and diaphragms from 147 of these animals.
Sera from animals from which diaphragm was available were immediately 
tested by the IHA and IFA methods as described in Chapter 3. Diaphragms 
from animals with high titres (<1:512 IFA, with IHA usually positive as 
well) were inoculated into mice in view of the correlation between titre 
and success of isolation found by Work (1971). Sera from the remainder 
of the animals were frozen at -20°C until tested by 'he IKA technique.
8.2 Resultr
Of the 895 sera tested by the IFA method, 97% (868) were positive at a 
titre of 31:16. Titres of up to 1:16 384 were found. DJ itribution of 
results according to titre is shown in Table 8.1.
Of the 147 sera also tested by the IHA method, 97% (143) were positive 
in the IFA test and 30% (44) in the IHA test, with IHA titres of 1:16 to 
1:1024 as shown in Table 8.2. The IHA method was used to obtain a rapid 
result to enable inoculation of diaphragm material into mice, but the 
method was not very successful as titres were generally lower than corres­
ponding I FA titres, and end-points were very difficult to interpret as they 
tended to fade out rather than give a clear-cut end-point.
Results of IFA tests on 895 sheep
3 27
8 75
24 215
26 233
24
6
218
54
3.5 31
2.7 24
1.5 13
0.2 2
0.2 2
0.1 1
t a b l e 8.1
IFA tttre
Negative (<1:16)
1:128
1:256
1:512
1:1024
1:2048
1:4096
1:8192
1:16384
NegativeIFA titre
Negative
1:128
1:256
1.512
1.1024
1:2048
TOTAL
Sample size
895
TABLE 8.2. Comparison of IFA and IHA results in sheep
IHA titre 
1:16 1:64 1:256 1:1024
2
3
Diaphragms from these sheep were inoculated into mice
Total
Diaphragm, representing skeletal muscle from the 19 sheep with IFA 
titres of $1:512, was inoculated into mice after peptic digestion in 
artificial gastric juice as described in Chapter 4. However, no
isolates of Toyvplaorna were obtained after 3 passages in mice, and all 
mice used remained seronegative. The only isolate obtained was an 
organism producing thick-walled brain cysts in the mice inoculated from 
one of the sheep. These cysts failed to fluoresce with direct anti- 
Toxoplasma conjugate, and may oe cysts of Basnoitia species.
8.3 Discussion
The finding of 97% of sheep to be seropositive, and therefore to have 
evidence of chronic toxoplasmosis, was extremely interesting in assessing 
the possible role of these and other meat-producing animals in the spread 
of toxoplasmosis to man. A high seropositivity rate was also noted by 
Bigalke (1978), who stated that of many sheep tested by him by the dye 
test method, he had hardly ever seen a negative result. Representative 
high and low titre sera from sheep in this study were checked in the dye 
test, and dye test titres within one doubling dilution of the IFA method 
were obtained. Other coccidia such as Besttoitia, Bavcoaystia, Fvenkelia 
and Harrmondia may cross-react in the IFA test, and may have affected the 
results obtained (Frenkel, J. Parasitol. 63:011-628, 1977).
Ovine abortion due to Toxcplaema has not been reported in the South 
African veterinary literature, probably a animals become infected before 
reaching maturity. Mutton and lamb are therefore almost always at risk 
of transmitting infection if eaten raw or undercooked. Fortunately, 
these meats are usually we11-cooked, and probably do not represent a 
major hazard unless eaten raw.
Failure to isolate Toxopl wrna from the diaphragms of the 19 high- 
titre seropositive animals was disappointing, but may have been due to 
the small number of diaphragms tested, the small amount of material used 
for digestion and inoculation, irregulai distribution of cysts, or killing 
of cysts during the digestion process.
i ivestigation of other meat-producing animals may yield high sero­
positivity rates as well, and all fresh meat products in South Africa 
should be regarded as potentially containing Tonvfplaama cysts.
9.0 CONCLUSIONS
Toxoplasma, has been snown to be an extremely successful and versatile 
parasite throughout the world, with both sexual and asexual stages in 
its life cycle. This parasite is now known to be a sporozoan, with 
the cat as its definitive hcst, and it is capable of optional rather 
than obligatory changes between definitive and intermediate hosts 
(Frenkel, 197 3a).
The findings presented here have shown that toxoplasmosis is present 
in Southern Africa, and thac acute infection and congenital transmission 
occur as expected from experiences reported in other parts of the world.
9.1 Prevalence and incidence of toxoplasmosis In Southern Africa 
The prevalence of Toxoplasma antibodies in over 10 000 sera, as shown in 
Chapter 5, is 21% overall, varying from 9% in the San of South West Africa 
and Botswana to 34% in Blacks and Indians in Natal. The overall annual 
seroconversion rate was 1* in the under 20-yea*- age group, falling to 0.5% 
in the over 50-year group. This fall was particularly prominent in the 
Western Cape, where prevalence hardly rose over the age of '•ri yars. This 
suggests that oocvst transmission may be more important than transmission 
via meat as there are no major cultural oi socio-economic differences 
between the Western Cape and the rest of the country, and meet supplied 
to the Western Cape comes from a wide area which also suppt - ne rest 
of the country. The finding of a lower prevalence 1 i Whiter- than in 
Blacks, Coloureds and Indians supports oocyst tran ml:aion, as Whites, 
being of higher socio-economic status could be les; exposed to oocysts 
but more exposed to rare meat.
The antibody prevalence found generally reflected climatic conditions, 
being lowest in the most arid areas and highest, in the high-iuinfall 
region of Natal, again suggesting oocyst transmission.
The groups studied in South West Africa and Botswana also yielded 
interesting contrasts between the San and the Negroid Dama. The Kalahari 
Deuert supports a number of San communities whose members obtain their 
meat from hunting buck and small mammals. They will, if given the 
opportunity, hunt and kill lion and other predators. The Dama, on the 
other hand, are a settled pastoral people, keeping goats and sometimes
sheep and cattle in the northern parts of South West Africa. In both 
the San and the Dama, hygiene is very primitive, although the San 
consume raw meat more often than do the Dama. Both groups keep dogs, 
but domestic cats are virtually unknown. The seropositivity rate in the 
Dama (27%) was significantly higher than that in the San (9%).
9.2 Toxoplasmosis in pregnancy in South Africa 
This was studied in 6705 patients in the Transvaal, and the results 
presented in Chapter 7. Twenty mothers with serological evidence of 
acute toxoplasmosis were detected (0.3%) and transmission occurred in 2 
of the babies born to these mothers. One of the affected babies was 
severely affected and the other was asymptomatic. The congenital infection 
rate found was therefore 0.03% or 3 per 10 000 births, with a foetal trans­
mission rate of 10%. With a:, estimated 627 000 births per year in South 
Africa, and C .4% incidence of maternal infection per year (0.3% for 9 
months’ gestation), 2 500 maternal infections per year would be expected. 
With a 10% foetal transmission rate, 250 congenital infections would be 
expected. These figures are probably minimum estimates and may be as high 
as double these estimates (see Chapter 5). The number of congenital cases 
detected ir this study was too small to give an estimate of the numbers of 
symptoms' ii and asymptomatic congenital infections, but if data frorri 
Desmonts and Couvreur (1973a) are applicable, 38 severe, 48 mild and 165 
asymptomatic congenital infections would be expected annually in aouth 
Africa. The 38 severe cases would represent 1 severe ungenital infection
per H 500 births or 0.006%.
9.3 Transmission cl toxoplasmosis in Southern Africa 
The evidence presented above has provided indirect data which indicate 
that oocyst transmission may be important in the younger age groups. 
Transmission of cysts via meat can certainly occur and probably accounts 
for a good proportion of infections, particularly in adults. However, as 
in other parts of the world, the role of the 2 methods of transmission, 
and the possibility of other methods existing, remains unresolved.
g .4 Virulence of South African Toxoplama strains 
Virulence in man is extremely difficult to evaluate, and the major 
difference shown in this study from the classic studies of Desmonts and 
Couvreur in France is the lower congenital transmission rate (Table /.13). 
However, when congenital infections do occur, the affected babies appear 
to be as severely affected as those described elsewhere. Lower congenital
sheep and cattle in the northern parts of South West Africa. In both 
the San and the Dama, hygiene is very primitive, although the San 
consume raw meat more often than do the Dama. Both groups keep dogs, 
but domest.c cats are virtually unknown. The seropositivity rate in the 
Dama (27%) was significantly higher than that in the San (9%).
9.2 Toxoplasmosis in pregnancy in South Africa 
This was studied in 6705 patients in the Transvaal, and the results 
presented in Chapter 7. Twenty mothers with serological evidence of 
acute toxoplasmosis were detected (0.3%) and transmission occurred in 2 
of the babies born to these mothers. One of the affected babies was 
severely affected and the other was asymptomatic. The congenital infection 
rate found was therefore 0.03% or 3 per 10 000 births, with a foetal trans­
mission rate of 10%. With an estimated 627 000 births per year in South 
Africa, and 0.4% incidence of maternal infection per year (0.3% for 9 
months' gestation), 2 500 maternal infections per year would be expected. 
With a 10% foetal transmission rate, 250 congenital infections would be 
expected. These figures are probably minimum estimates and may be as high 
as double these estimates (see Chapter 5). The number of congenital cases 
detected in this study was too small to give an estimate of the numbers of 
symptomatic and asymptomatic congenital infections, but if data from 
Desmonts and Couvreur (197 3a) are applicable, 38 severe, 48 mild and 165 
asymptomatic congenital infections would be expected annually in South 
Africa. The 38 severe cases would represent 1 severe congenital infection
per 16 500 births or 0.006%.
9.3 Transmission of toxoplasmosis in Southern Africa
The evidence presented above has provided indirect data which indicate 
that oocyst transmission may be important in the younger age groups. 
Transmission of cysts via meat can certainly occur and probably accounts 
for a good proportion of infections, particularly in adults. However, as 
in other parts of the world, the role of the V methods of transmission, 
and the possibility of other methods existing, remains unresolved.
9.4 virulence of South African Toxoplasma strains 
Virulence in man is extremely difficult to evaluate, and the major 
difference shown in this study from the classic studies of Desmonts and 
Couvreur in France is the lower congenital, transmission rate (lable /'.13) . 
However, when congenital infections do occur, the affected babies appear 
to be as severely affected as those described elsewhere. Lower congenital
vr.M . .ion •) t.T u ih r i>..r t.v,> t, K,.mce were found in stupes 
in North America and England, and strain differences could account for these 
variations. South African strains would be amongst those resulting V.i 
the lowest congenital transmission rates in the world.
No explanations for these differences in congenital transmission 
rates are available, other than that they may reflect differences in
virulen< e.
9.5 Diagnosis of toxoplasmosis 
Criteria for the serological diagnosis of toxoplasmosis in Southern 
Africa are similar to those described elsewhere. IFA seroconversion with 
positive IgM-IFA and CFTs are diagnostic in most cases, but problems can 
occur as these tests are not standardised in many laboratories. Persons 
incidentally found to have serological evidence of chronic infection are 
often diagnosed and treated for acute infections. Diagnostic criteria 
for acquired toxoplasmosis are presented in Table 9.1.
TABLE 9.1. Diagnostic criteria for acquired toxoplasmosis
Presentation
Clinical
features
Serology*
Hlsto-
pathology
Treatment
acute recrudescent
localized or encephalitis, 
generalized myocarditis, and 
iymphadeno- pneumonitis in 
pathy compromised host
chronic
asymptomatic
nil
IFA positive IFA positive,
titre usually titre 1:16 to
high, and IgM-IFA 1:512, CFT and
and CFT can be IgM-IFA nega- 
positive five
IFA sero­
conversion, 
rise in 
titre, or 
single 
titre 
51:1000 
with posi­
tive IgM-IFA 
or CFT
Toxoplaema Toxoplasma
lymphadenitis encephalitis,etc.
Nil if asymp- Pyrimethamine Nil
tomatic and sulphadia-
zine
chronic
symptomatic
retino-
choroiditis
IFA positive 
but titres 
can be low, 
and IgM-IFA 
and CFT
u.aally 
negative
Toxoplaema
retino-
choroiditis
Pyrimethamine, 
sulphadiazine 
and steroids 
if active or 
progressive
* Dye test may be used instead of IFA test
1 1 7 .
The diagnosis of congenital infections depends on the demonstration 
of Toxoplasma IgM-lFA cr CFT antibodies in babies1 sera at birth, with 
these tests remaining positive after the age of 6 months, when maternal 
antibodies should have disappeared. Diagnostic criteria for congenital 
infection are presented in Table \%2.
TABLE 9.2. Diagnostic criteria for congenital toxoplasmosis
Presentation severe infection mild infection asymptomatic
Clinical
features
hydrocephalus, retinochoroidi-
intracranial cal- tis
cification,
retinochoroiditis,
encephalitis,
hepatosplenomegaly,
etc.
nil
Serology IFA, IgM-IFA and CFT positive at birth 
positive past the age of 6 months. 
Maternal serology also positive.
, and remain
Treatment Pyrimethamine and sulphonamides, even 
at birth.
if asymptomatic
9.6 Public health significance of toxoplasmosis in South Africa 
The major public hea-th role of toxoplasmosis is its causation of severe 
congenital infection. From the data presented in this study, 1 to 2 severe 
Toxoplasma infections per 16 500 births (0.006% to 0.012% of births) or 
38 to 76 cases (including abortions) per year are estimated to occur in 
South Africa.
As there are at present no means such as immunization to prevent 
maternal infection as there are in rubella, the only possible control 
measure would be the serological diagnosis of maternal infections during 
pregnancy. As 79% of patients are seronegative on becoming pregnant, 
this would entail follow-up of about 500 000 women per year. Frequent, 
serological testing would be required, and the only possible inter­
vention would be treatment of mothers with spiramycin as therapeutic 
abortion would not be justified, or could not be done in late pregnancy.
As the serological techniques in toxoplasmosis are not nearly as 
simple as the reagin tests used to screen for syphilis in pregnancy, major 
laboratory facilities and trained staff would have to be provided for such 
a control programme.
From the practical point of view, control of toxoplasmosis is obviously 
impossible in view of the small number of severe congenital infections
1 1 8 .
that occur?, the problt.-ns associated with adequate diagnostic facilities, 
the '.w presentation o- airy i • it lent- for antenef^ cfre it at all, and*' 
the higher priority for the control of diseases such as tuberculosis, 
measles, syphilis md malnutrition in South Africa. The only practical 
measure worth taki: v would be to publicise the measures advocated by 
Frenkel (1974), whici nclude control of cats and avoidance of possible 
contact with cat faecc^ and raw meat during pregnancy (see 1.12).
As the prevalence and incidence of toxoplasmosis in Southern Africa 
are low, and the transmission rate during acute infections in pregnancy 
is also particularly low compai id with that in other parts of the world, 
contrcl measures would be of very little overall benefit to the community. 
Many severe infections result in abortion cr neonatal death, and the cost 
of screening programmer during pregnancy would be prohibitive. Very 
Httle can, in any case, be done to prevent congenital transmission other 
than to avoid sources of infection during pregnancy.
Until vaccination becomes a reality, w » will have to live with the 
small, although significant, threat of congenital toxoplasmosis.
Screening for toxoplasmosis during pregnancy is not advocated for the 
reasons given above, -although the risk of congenital infection can be 
reduced by simple measures such as education of pragnant women to wash 
their hands prior to touching their ‘aces or ea .g.
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APPENmx 2.3. RARAUWANATH HOSPITAL, I FA 5 512, CFT negative, 
babies bled within J days of birth as cord 
blood not submitted
Delivery - Maternal Neonatal
Patient ______________________ ____________________
NO. IFA IgM-IFA CFT IFA IgM-IFA CFT
B501 2048 16 - 1024
B502 512 16 - 256
B503 512 - 512
B504 512 - - 512 - -
B505 512 16 — 256 - —
B506 512 - — 256 — —
B507 512 32 - 1024
B508 512 - •• 512
B509 512 - 256
B510 512 - 512
APPENDIX 2.4. BARAGWANATH HOSPITAL - IFA positive <1;512, 
CFT negative, cord blood not submitted
Patient Delivery - Maternal
No. IFA CFT
B517 
B518 
9519 
B520 
B521 
B522 
B523 
B524 
B525 
B526 
B527 
B528 
B529 
B530 
B531 
B532 
B533
Patient
No.
BS34
B535
B536
95:7
B538
B539
B540
BShil
B542
B543
B544
B545
B54G
B547
B548
Delivery 
I FA
Maternal
CFT
16 - B549 32
32 - B550 32
32 - B551 32
64 - B552 16
16 - B553 16
128 - B554 16
128 - B555 16
32 - B556 128
128 - B557 16
128 * B558 16
64 - B559 32
64 - B560 256
32 - B561 32
- B562 64
128 - B563 128
32 - B564 16
32 - B565 64
64 - B566 32
16 - B567 128
25b - B568 32
16 • B569 32
64 - B570 256
256 - B571 16
128 - B572 64
128 - B573 16
16 - B574 128
32 - 9575 16
16 - B576 16
16 - B577 64
32 - B573 64
32 — B579 128
16 • B580 16
Patient Delivery - Maternal
No. IFA Cr'T
Patient Delivery - Maternal
No. IFA CFT
B581
B582
B583
B584
B565 
B586 
B587 
B588 
B589 
B590 
B591 
B592 
B59 j 
B594 
B595 
B596 
B597 
B598 
K599 
B600 
B601 
B602
B607 
B6C8 
B609 
B610 
B611 
B612 
B613 
B614
16
64
16
16
16
16
16
16
64
54
32
128
128
256
128
16
64
64
32
16
32
16
16
")56
64
32
32
16
128
128
32
256
128
16
B615 
B616 
8617 
B618 
B619 
B620 
2621 
B622 
8623 
B624 
B625 
B626 
B627 
B628 
B629 
B630 
B631 
B632 
B633 
B634 
B635 
B636 
B637 
0638 
B639 
B640 
B641 
3642 
B64 i 
B644 
B645 
BC46 
B647 
B649
16
128
64
16
32
32
64
256
16
32
256
16
16
256
32
16
128
32
16
16
32
16
32
64
32
64
16
16
16
16
16
128
16
32
Patient 
No.
Delivery - 
I FA
Maternal
CFT
B649 16 -
B650 16 -
B651 256 -
B652 128 -
B653 16 -
B654 16 -
B655 16 -
B656 16 -
B657 16 «
B658 16 -
B659
B66C
B661
B662
B663
B664
B665
B666
B667
B668
B669
B670
Bt>7?.
3672
B673
B674
B675
B676
B677
B678
B6/9
B680
B681
B682
64 
128 
64 
32 
32 
64 
64 
16 
64 
16 
64 
32 
64 
16 
64 
128 
16 
16 
16 
32 
16 
16 
512 
16
Patient
No.
B683
B684
B6C5
B686
B687
B688
B689
B690
B691
B692
B693
bi 1
B695
B696
B697
B698
B6S9
B70G
B701
B702
B703
B704
B7G5
B706
B707
B708
B709
B710
B711
B712
B713
B714
B715
B-/16
Maternal 
CFT
Delivery 
IFA
Patient 
No.
Delivery - Maternal 
IFA CFT
Patient 
No
B7b 1■717
B718
B753B719
B754n 12Q
B760B v
B727
B762B728
B763B729
B764B730
B76L,B731 
B732
B767B733
B734
B770B736
B7 37
B772
B77 3
B74?
B743
B778B74 \
B779
B780B/46
B781 
8782#B74L
B783
B784
874*3
   -------
Patient Ivery - Mater. Patient
No. I FA CPI' * No.
B785 64 *
B786 256 -
B787 256 —
B788 16 -
3788 256 -
B7-30 128 -
B791 256 * .
B792 .6 -
B793 64 -
B794 128
B79S 16 1 -
B796 64 -
B797 128 -
B798 256 -
B799 128 -
B800 16 -
B80t 128
::
B807
B808
32
Patient Delivery - Maternal
No. I FA CFT
B853 64 -
B854 32 -
B855 16 -
B856 128 -
B857 32 -
B858 16 -
B859 32 -
B860 16 -
B861 16 -
B862 32 -
B863
B864 -
B865 32 -
B866 32 -
B867 16 -
B868 22 -
B869 3 2 * -
B870 64 -
B871 16
B872 32 If
B873 16 -
B874 16 -
B875 32 -
B876 16 -
B877 32 —
B878 16 —
B879 16 —
B880 16 -
BW91 16 -
B882 16 -
B8R3 16 w
B884 32 -
Patient
No.
B087
B888
B889
B890
B891
B892
B893
B894
B895
B896
B897
B898
B099
B900
B901
B902
B9C3
B904
B9Q5
B906
B907
B908
B909
B910
B911
B9 1 2
B9 1 3
B91 4
B'» 1 5
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